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Abstract
Velocardiofacial Syndrome (VCFS) is a genetic disorder characterized by numerous
physiological and psychological symptoms. Little is known regarding the neuropsychological
and hormonal substrates and the social functioning in individuals with VCFS. There is some
evidence to suggest that the stress hormone cortisol contributes to social, cognitive, and
communication deficits in related populations (Corbett, Schupp, Levine, & Mendoza, 2009).
This study investigated the role that cortisol has on the social and cognitive impairments
observed in children with VCFS. To this end, 11 children with confirmed VCFS were assessed
for baseline cortisol levels and received neuropsychological testing that assessed attention,
memory, language, and social functioning. These results were compared with the results from
11 controls that were matched according to age and sex. It was hypothesized that children with
VCFS would have significantly higher baseline cortisol levels relative to control children.
Additionally, these cortisol levels would be negatively correlated with measures of social
functioning as measured by CBCL, ABAS-II, and RCMAS-2. Furthermore, it was hypothesized
that cortisol levels would be negatively correlated with performance on cognitive tests.
Specifically, it was hypothesized that cortisol levels in children with VCFS would be negatively
correlated with tests of attention and memory as measured by the WRAML-2. Children with
VCFS had significantly higher cortisol levels than control counterparts; F(1, 20) = 5.436, p <
.05. Cortisol levels in VCFS were not related to measures of social functioning or measures of
cognitive functioning. That said, a significant negative correlation was observed between the
General Memory and Attention/Concentration indices of the WRAML-2 and cortisol
concentrations in the control population: r(11) = -.78, p <.05; r (11) = -.62, p < .05.
Additionally, the level of cortisol in control individuals was negatively correlated to the social
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competency scale of the CBCL; r(11) = -.64, p < .05. These results support the role of
neurohormonal substrates such as cortisol in social impairment and cognitive functioning in
neurotypical children. More generally, these data provide evidence of a possible causal
mechanism that underlies social impairments in other stress disorders known to involve cortisol
dysregulation. Furthermore, these data add to the understanding of the interaction between
stress, cortisol, and cognition are indicative of possible treatment targets for cognitive and social
interventions.
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Introduction
Velocardiofacial syndrome (VCFS) is a genetic disorder that has a number of
physiological and psychological symptoms. VCFS is one of the most common genetic disorders
and one of the most common causes of learning disability and mild mental retardation (Eliez et
al., 2001; Gothelf & Lombroso, 2001). Though the physiological symptoms associated with
VCFS have been thoroughly studied, there is much to be understood with regard to the
psychological features of the disorder. In particular, the neurochemical substrates underlying
many of the social impairments expressed in these individuals have yet to be explored. Further
examination of the neural substrates of social functioning in this population may provide insight
into the brain-behavior relationships of social cognition. A review of the specific impairments
associated with VCFS with an emphasis on their neuroanatomical and neurochemical substrates
will be presented along with the role that cortisol plays in social impairment and
psychopathology in other disorders. Specifically, this introduction will review the history of
VCFS, the prevalence of the disorder, and the diagnostic tests used to identify the disorder.
Furthermore, the physical, psychiatric, cognitive, and social deficits will be described along with
the neurological, neurochemical, and neurohormonal anomalies associated with these symptoms.
Finally, an experiment will be described in order to address a significant void in the literature
regarding the etiology of social and cognitive impairments in this population.
History of VCFS Discovery
Velocardiofacial Syndrome was first described by Kirkpatrick and DiGeorge in 1968 as a
constellation of immunologic deficiencies. It was renamed Shprintzen Syndrome following a recategorization of the common presenting symptoms (Shprintzen et al., 1978). Shprintzen (1978)
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described palate anomalies (“velo”), congenital cardiovascular defects (“cardio”), and mild facial
dysmorphism (“facial”) as characteristic of individuals with this particular disorder. Despite the
consistent reemergence of the aforementioned symptoms, there is a great deal of symptom
heterogeneity expressed in these individuals, which made it difficult to conclude that these
individuals actually had the same disorder (Shprintzen et al., 1978). In order to definitively
categorize these seemingly independent symptoms as being part of a single disorder, it was
necessary to link the immunologic deficiencies noted by Kirkpatrick and the symptoms noted by
Shprintzen with a common etiology. It was discovered that all of the individuals expressing
some combination of the symptoms described by Kirkpatrick and Shprintzen had a microdeletion
in the long arm of chromosome 22 at band 22q11.2 (Kelly et al., 1993). This finding allowed
researchers to definitively conclude that the multitude of symptoms were part of the same
syndrome. As research has progressed, the number of diagnostic symptoms has increased. At
present, there are over 180 phenotypic characteristics of VCFS including congenital
abnormalities, learning disabilities, and psychiatric disturbances (Gothelf, 2007). This has
prompted researchers to begin using the title 22q11.2 deletion syndrome as opposed to VCFS,
though the terms are still used interchangeably.
Prevalence and Diagnostic Tests
Despite consistent agreement among practitioners regarding the constellation of
symptoms associated with VCFS, the exact prevalence of VCFS is difficult to ascertain.
However, the best estimate to date is 1 in 5900 (Botto et al., 2003). The actual prevalence is in
all likelihood much higher than this figure (Gothelf, 2007). Gothelf identifies several reasons for
the inability to get an accurate prevalence rate. First, only “at-risk” infants are screened for the
disorder. Second, the phenotypic and cognitive symptoms can be quite mild, resulting in a lack
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of diagnosis or delayed diagnosis. Third, the heterogeneous symptom presentation often leads
clinicians to make erroneous diagnoses.
Despite these barriers to gauging prevalence accurately, recent advances in genetic
screening have enabled clinicians to determine with great accuracy whether a cluster of
symptoms found in an individual is due to VCFS. Using Florescence In Situ Hybridization
(FISH), clinicians can determine whether a micro-deletion exists on chromosome 22 (Driscoll et
al., 1993). As a result, FISH has become the “gold standard” diagnostic test for VCFS. Though
the diagnosis of VCFS can be made accurately and reliably, the cost of testing (approximately
$1000 per test) is a major barrier to expansive infant screening. Future variants of the FISH test
are likely to be more cost-effective, which would make widespread infant screening for the
disorder feasible. Researchers will then be able to determine with greater accuracy the
prevalence of the disorder. Despite difficulties accurately assessing prevalence, the physical
symptoms associated with VCFS have been extensively examined. The following section will
describe the physical anomalies associated with VCFS.
Common Physical Symptoms Associated with VCFS
There are a wide range of physical symptoms associated with VCFS. These symptoms
can be grouped into 5 categories. The first symptom category is congenital cardiac anomalies.
These anomalies occur in nearly 75% of all individuals with VCFS and include tetralogy of
fallot, ventricular septal defects, and truncus arteriosus (Digilio et al., 2005). The second
symptom category is abnormal faces (Gothelf, 2007). These facial anomalies are common in
individuals with VCFS and include hypoplastic alae nasi, a prominent nasal root, elongation of
the face with cheek flattening, narrow-set eyes, a small mouth, and a retruded chin. Many times
these are the most prominent diagnostic features of VCFS. The third symptom category is
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palatal abnormalities, which occur in approximately 75% of individuals with VCFS (Kirscher,
2005). Specifically, these anomalies include a defective palate and hypernasal speech. The
fourth symptom category includes T-cell immunodeficiency (Gothelf, 2007). According to
Kirkpatrick and DiGeorge (1968), this deficiency results from a hypoplastic parathyroid and
thymus. The fifth symptom category consists of a heterogeneous set of other physical symptoms
that covary with the disorder such as growth retardation, juvenile rheumatoid arthritis, and
urinary tract abnormalities (Gothelf, 2005).
Etiological analysis of these symptoms has occurred on multiple levels. At the
embryonic level, most of the symptoms observed appear to result from impaired migration of the
neural crest cells (Prescott et al., 2005). These cells are the prelude to the formation of the
mesenchyme of the third and fourth pharyngeal arches. From these arches emerge the face, cleft,
thymus, parathyroid gland, and cardiovascular system. Thus, interference with the migration of
the crest cells can result in a deleterious cascade in which numerous biological systems are
impacted. Furthermore, this embryonic explanation accounts for the symptom heterogeneity
observed in individuals with VCFS. That is, the level of impairment in the neural crest cell
migration dictates the range of biological systems affected and the severity with which the
pathology presents.
Another level of etiological analysis is genetic (Gothelf, 2007). One theory regarding the
genetic etiology of VCFS is haploinsufficiency. Haploinsufficiency occurs when only a single
functional copy of an essential gene is produced, resulting in insufficient gene product. Funke,
Pandita, and Morrow (2001) noted that haploinsufficiency of one or more of a combination of
genes may account for a multitude of the physical and psychiatric symptoms associated with
VCFS (Funke, Pandita, & Morrow, 2001). In support of this, McDermid and Morrow (2002)

4

performed a knockout mutation for the TBX1 gene (McDermid & Morrow, 2002). TBX1 codes
for a protein that is expressed in great quantity throughout numerous brain regions (Paylor et al.,
2006). Compared to control mice, TBX1 “knockout” mice experienced numerous
developmental abnormalities. Many of these abnormalities were correlates of the pathologies
associated with VCFS. The deficits included cardiac abnormalities, abnormal facial structures,
deformed vertebrae, and cleft palate. Thus, it is conceivable that VCFS might be related to
genetic abnormalities of the TBX1 gene. Furthermore, the variable expression of the TBX1
protein explains the wide range of symptom heterogeneity in VCFS.
To conclude, there are two prominent theories regarding the etiology of impairment in
this population. The first is the embryonic theory, which incorporates the concept of neural crest
migration. The second theory is genetic, which suggests that limited protein expression from
TBX1 mediates the symptomatology of VCFS. Both of these etiological theories account for the
numerous symptoms associated with VCFS and the heterogeneity of symptom expression.
However, more research is needed to determine how these two causal factors interact.
Psychiatric Symptoms of VCFS throughout the Lifespan
In addition to many physical disorders that are observed in individuals with VCFS, there are
numerous comorbid psychiatric disorders (Arnold, Siegel-Bartelt, Cytrynbaum, Teshima, &
Schachar, 2001; Feinstein, Eliez, Blasey, & Reiss, 2002; Fine et al., 2005; Gothelf et al., 2003;
Gothelf et al., 2004; Lachman et al., 1996; Shprintzen, 2000). These psychiatric disturbances
emerge at different times throughout the lifespan. For example, during childhood, one
psychiatric disturbance in individuals with VCFS is ADHD (Arnold et al., 2001; Feinstein et al.,
2002; Lajiness-O'Neill et al., 2006). This is one of the most common psychiatric correlates, with
a prevalence rate of about 35% to 46% in individuals with VCFS. In addition to ADHD, a
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significant proportion of children with VCFS present with non-verbal learning disorders
(Lajiness-O'Neill et al., 2006). Anxiety disorders are also commonly diagnosed in children with
VCFS (Gothelf et al., 2003; Prinzie et al., 2002). Specifically, VCFS children present with
generalized anxiety disorder, separation anxiety disorder, obsessive compulsive disorder, and
specific phobias. Affective disorders are also often comorbid with VCFS (Arnold et al., 2001;
Feinstein et al., 2002). Arnold et al. (2001) noted high rates of depression among childhood
samples of VCFS individuals. Furthermore, bipolar disorder was found in 66% of children with
VCFS who demonstrated affective symptomatology (Papolos, Faedda, Veit, et al., 1996). Last,
children with VCFS have a high prevalence rate of pervasive developmental disorders. For
example, approximately 14%-45% of children who have VCFS also meet criteria for Autism
Spectrum Disorder (ASD; Antshel et al., 2007; Fine et al., 2005; Niklasson, Rasmussen,
Oskarsdottir, & Gillberg, 2001; Vorstman et al., 2006).
During late adolescence and throughout adulthood, a different pattern of psychiatric
symptomatology emerges (Gothelf, 2007). For example, VCFS adults have much more severe,
persistent anxiety than that observed in children with VCFS (Gothelf, Feinstein, et al., 2007). In
addition, 32% of individuals with VCFS will develop schizophrenia or other psychotic disorders
during late adolescence or early adulthood. Having 22q11.2 deletion syndrome is the single
greatest genetic predictor of the development of schizophrenia (Murphy et al., 1999). These
individuals are 25 times more likely to develop schizophrenia than the general population
(Turner, 1989). Murphy (2002) noted that the prevalence rate of schizophrenia in individuals
with VCFS is higher than in children with a schizophrenic parent (Murphy, 2002). This
increased risk of schizophrenia and other psychiatric illness has led researchers to conceptualize
VCFS as a significant genetic diathesis for the development of these disorders.
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Cognitive Deficits and their Neurological Correlates in Patients with VCFS
In addition to the numerous psychiatric illnesses associated with VCFS, there are
multiple cognitive impairments of note. For example, individuals with VCFS frequently have a
Borderline IQ (Swillen et al., 1997). According to Swillen et al., approximately 25% to 40%
have an IQ below 70 and meet criteria for Mild Mental Retardation.
Furthermore, deficits in attention, cognitive flexibility, and working memory are common
(Gothelf, Furfaro, Penniman, Glover, & Reiss, 2005). Many of these deficits have been
associated with impaired executive network efficiency (Sobin et al., 2004). The specific
attention deficits can be ascribed to malformations of the head of the caudate nucleus (Sugama et
al., 2000). Sugama (2000) noted that patients with VCFS had a larger right head of the caudate
relative to the left head, whereas controls demonstrated the reverse trend. Interestingly, this
same trend has been consistently identified in individuals with ADHD (Castellanos et al., 1994;
Castellanos et al., 1996; Hynd et al., 1993). Taken together, these data suggest that this
particular neuroanatomical anomaly mediates attention and other cognitive deficits in individuals
with VCFS.
In addition to malformations of the caudate, it has been hypothesized that because people
with VCFS have such large volumetric and activation differences in brain structures implicated
in working memory compared to typically developing people, people with VCFS recruit a novel
network of brain structures during performance of working memory tasks. Additionally, studies
have demonstrated poor performance of tasks of verbal and visuo-spatial working memory by
individuals with VCFS (Kates et al., 2006; Lajiness-O'Neill et al., 2005). Kates et al. (2007)
sought to investigate this aberrant memory performance. They scanned the brains of 17 children
and youth with VCFS, 10 of their siblings without the disorder and 10 healthy controls from the
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wider community using fMRI. Their experimental design was similar to the commonly used
Go/NoGo design. These researchers found no significant differences in reaction time or d-prime,
a statistic based on a combination of the hit rate and false alarm rate. However, they found that
controls activated the right middle and inferior frontal gyri, left and right inferior and superior
parietal lobules, and left and right occipital lobes to a significantly greater degree than VCFS,
whereas participants with VCFS activated the left orbitofrontal cortex, right cingulate, and the
right cuneus and occipital cortex more. This lends credence to the hypothesis that people with
VCFS activate a different neural network during working memory tasks than people without the
disorder.
Another interesting study examining working memory function in people with VCFS
used a directed forgetting paradigm (Debbané et al., 2008). In this method, a series of items are
presented (e.g., words, pictures), some labeled “to be remembered” and some labeled “to be
forgotten.” This selective encoding strategy usually encourages greater encoding efficiency for
the “to be remembered” items and leads to a directed forgetting effect (DF effect) for the “to be
forgotten”’ items. The researchers employed this paradigm and hypothesized that people with
VCFS would show decreased DF effects, similar to previously obtained results of people with
schizophrenia. The experimental groups were 33 individuals with VCFS aged 10-36 years old,
and a control group of typically developing individuals in the same age range, matched on sex to
the VCFS group. Repeated-measures analysis of variance (ANOVA) demonstrated a main effect
for directed forgetting across groups, as would be expected. In other words, more “to be
remembered” items were correctly identified than “to be forgotten items.” However, there was
no between-group effect, indicating the participants with VCFS were not significantly less likely
to correctly identify the “to be remembered” items. This contradicts their hypothesis and
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supports a view that people with VCFS are able to selectively process stimuli during encoding at
a level similar to typically developing individuals, implying that working memory systems are
not necessarily involved in memory impairments observed in VCFS.
In conjunction with deficits in attention and working memory, individuals with VCFS
also display impairments in response inhibition. This response inhibition has been associated
with abnormal activation of the parietal cortex (Eliez et al., 2001). Gothelf et al. (2007) noted
that individuals with VCFS performed comparably to controls on the Go/No Go response
inhibition task (Gothelf, Hoeft, et al., 2007). However, VCFS individuals showed additional
activation in superior and inferior parietal regions in conjunction with frontal-striatal processes,
suggesting that more neurocognitive resources were necessary in order to inhibit particular
responding. These results, taken together with the observed attentional impairments, may
account for the high rate of ADHD in individuals with VCFS.
In addition to response inhibition difficulties, individuals with VCFS also show
impairment in visuospatial and numerical abilities. These impairments have been associated
with structural deficits of the parietal lobe (Eliez et al., 2001; Kates et al., 2004). Eliez et al.
(2001) observed increased activation of the left supramarginal gyrus (LSMG) as a function of
computational difficulty in individuals with VCFS. No such trend was observed in age-matched
controls. The authors concluded that the increased LSMG activation occurred as a result of
parietal deficits and may contribute to limitations in numerical, mathematical, and spatial
reasoning abilities in this population and account for the commonly observed NLD profile
identified by Lajiness-O’Neill et al. (2005). Moreover, Lajiness-O’Neill et al. (2005) observed
deficits in visual learning and facial memory in children with VCFS and their sibling controls
and concluded that this specific cognitive profile may be the result of a disruption in the ventral-

9

temporal pathway that occurs independent of the microdeletion itself. Specific structures
implicated by Lajiness-O’Neill (2005) that may be impacting memory performance were the
fusiform gyrus and the parahippocampal/hippocamapal regions. Given that it is not the presence
of VCFS alone mediating these specific cognitive deficits in this population, it is possible that
other factors may contribute to this broader phenotype observed in the siblings of children with
VCFS. Additionally, as will be discussed in the section on social processing, deficits in facial
memory are associated with poor social competence and social skills deficits (Ennis & Whelton,
1994). Thus, the pervasive nonverbal memory deficits observed in this population may also
contribute to the significant social impairment observed in this population.
In addition to the aforementioned nonverbal memory deficits observed in individuals
with VCFS, this population also exhibits some verbal working memory deficits (LajinessO'Neill, 2005). On tests of verbal working memory, children with VCFS performed significantly
worse than their sibling counterparts. These data suggest that the verbal working memory
deficits observed in this population or more closely associated with the unique features of the
microdeletion as opposed to a broader mechanism.
To summarize, individuals with VCFS have a number of cognitive deficits. These
deficits include attention, working memory, memory, cognitive flexibility, response inhibition,
visuospatial abilities, numerical processing, and language processing. Many of these deficits
have neuroanatomical correlates that may account for poor performance on related tasks.
Indeed, it is possible that many of these cognitive deficits and their neurological etiology
contribute directly or indirectly to the many social deficits observed in individuals with VCFS.
Specifically, it is likely that working memory deficits, language impairment, and verbal and
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nonverbal learning deficits contribute significantly to social impairment. These social deficits
will be the primary focus of the remainder of this introduction.
Social Impairments Observed in Individuals with VCFS
Though the physical symptomatology and genetic features of the disorder have been
widely studied, there has been little advancement in the understanding of social phenotypes in
VCFS and other genetic neurodevelopmental disorders (GNDD’s; Gothelf, Feinstein, et al.,
2007). One reason for this lack of research pertaining to the social deficits of these disorders is
simply a failure to include assessments of social functioning when conducting research on these
individuals. Frequently, the psychotic features, cognitive deficits, and genetic correlates take
precedence when conducting research on GNDD’s (Gothelf, Feinstein, et al., 2007).
Furthermore, diagnostic overshadowing has been problematic in elucidating the specific social
deficits in VCFS. Specifically, the cognitive impairments are viewed as the etiology of social
features and therefore little concern is placed on determination of independent etiologies for
these social deficits (Hodapp & Dykens, 2005; Jopp & Keys, 2001). Indeed, these cognitive
impairments contribute to the observed deficits in social functioning; however, there is
neuroanatomical evidence suggesting that there is an etiology for the social deficits in VCFS that
is independent of their cognitive limitations. Moreover, there is evidence from other
neurodevelopmental disorders that low IQ is unrelated to social functioning. For example,
individuals with William’s Syndrome exhibit highly social behavior despite having a lower IQ
relative to normal controls (Steinlin, 2007). In other words, there is something about the specific
cognitive profile of individuals with VCFS that contributes to the social impairment in this
population.
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Despite being overlooked throughout the history of VCFS research, recent research has
identified a number of social deficits that commonly occur in individuals with VCFS. One such
social deficit is impaired social communication. Interestingly, these individuals develop normal
communication skills throughout the first two years of life, but then show significant delays
acquiring the ability to use short phrases and sentences. Furthermore, their speech is typically
unintelligible due to the emergence of compensatory articulation patterns (Golding-Kushner,
Weller, & Shprintzen, 1985). The most common compensatory articulation in children with
VCFS is the implementation of glottal stop substitutions (Shprintzen, 1997). As result of such
communication difficulties, few utterances are understood and early speech attempts may not be
reinforced or encouraged leading to further disintegration of communication abilities.
Another social deficit that may emerge as a result of these communication issues is
extreme shyness and withdrawal (Shprintzen, 2000). Swillen et al. (2001) administered the
Child Behavior Checklist (CBCL) to both individuals with VCFS and individuals with speech
pathology and learning impairments. They found that individuals with VCFS exhibited
significantly more withdrawal behavior, suggesting that the speech difficulties in VCFS interact
with other features of the disorder to contribute to social withdrawal (Swillen, Devriendt,
Ghesquiere, & Fryns, 2001).
One of the social deficits that may result from the shyness and social withdrawal is a
failure to initiate interactions (Eliez et al., 2000). In their case study describing the language,
speech, and psychological features of five individuals with VCFS, Eliez et al. (2001) noted a
significant deficit in the number of attempts made to interact. The authors attributed this social
deficit to communication difficulties and the tendency to engage in more withdrawn behaviors.
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In addition to their initiation deficits, VCFS individuals also show deficits in facial
recognition (Stiers et al., 2005). Stiers and colleagues (2005) noted that the substantial
impairments in facial recognition correlated with decreased volume of the right inferior parietal
and superior occipital lobe. In addition, there was a pronounced reduction of white matter
behind the inferior frontal gyrus relative to controls. Thus, it is possible that the social deficits
observed in these individuals relating to their inability to recognize faces may be mediated by
abnormalities in these brain areas.
Further contributing to deficits in social functioning are impairments in processing facial
expressions (van Amelsvoort et al., 2006). VCFS individuals perform significantly worse on
facial emotional processing tasks compared to age- and IQ-matched controls. This deficit was
associated with decreased activation in the right insula and frontal lobe. Alternatively, there was
increased activation in occipital regions in VCFS patients relative to controls. The authors
concluded that these genetically determined neuroanatomical anomalies might significantly
contribute to social deficits due to their involvement in emotional processing.
In addition to their emotional processing difficulties, VCFS individuals have distinct
personality characteristics that color many of their social interactions. VCFS individuals are less
conscientious, less emotionally stable, more irritable, and more dependent than normal controls
(Prinzie et al., 2002). Furthermore, VCFS individuals have been shown to have severe
attachment and anxiety issues, which may contribute to or exacerbate their personality deficits.
For example, Shprintzen (2000) noted age-inappropriate separation anxiety in VCFS individuals
when compared with normal controls. Also, children with VCFS are more phobic and present
with obsessive compulsive personality disorder more frequently than controls (Papolos et al.,
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1996). Indeed, the personality characteristics and anxious symptoms of people with VCFS
greatly impede social development.
Last, these individuals show affective abnormalities that interfere with social relations.
People with VCFS have been shown to have a flatter affect than normal controls during
engagement in social interactions. Furthermore, their facial response tends to be expressionless
during social engagements that usually facilitate both affective and facial responses (GoldingKushner et al., 1985). Indeed, this would make it difficult for individuals with VCSF to sustain
conversations with others and provide reinforcing feedback to those with whom they are
communicating. As a result, these individuals may have shorter interactions with individuals
they are meeting for the first time.
In summary, individuals with VCFS have numerous features contributing to their social
deficits. It is likely that many of the genetically prescribed neuroanatomical anomalies
associated with VCFS contribute to these deficits. The following section will identify etiological
theories for these social deficits.
Etiology of Social Impairments
One prominent theory regarding the etiology of social deficits in VCFS individuals
suggests that the language deficits are the foundation for the other social impairments.
Shprintzen (2000) argues that the language deficits observed in these individuals leads to
ineffectual communication skills. These ineffectual communication skills then lead to social
isolation due to lack of social reinforcement. Oftentimes these children are ridiculed for their
poor communication skills, leading to withdrawal and the formation of social anxieties. In this
way, language impairment can account for a number of other social peculiarities associated with
the disorder.

14

Another physiological explanation for the etiology of social deficits is lesions. White
matter hyperintensities and cysts have been consistently observed in individuals with VCFS
(Mitnick, Bello, & Shprintzen, 1994). The individuals presenting with these abnormalities have
the characteristic behavioral and social deficits commonly observed in this population. Though
the lesions were not statistically related to the behavioral deficits, it is possible that they interact
with other structural abnormalities to produce the social disturbances.
Additionally, there has been some work identifying specific brain structures and subnuclei that have been associated with the social deficits observed in this population. For
example, one study found significant volumetric changes in amygdala, prefrontal cortex, and
orbitofrontal cortex (Kates et al., 2006). These volumetric differences were positively correlated
with impaired performance on social competency scales such as the CBCL and other parent
report measures. Thus, as amygdala volume increased in size, symptom endorsement regarding
social competency increased.
With regard to the amygdala, Kates et al. (2006) noted that after controlling for total
brain size, the amygdala to prefrontal cortex ratio in VCFS patients was found to be significantly
larger than in sibling controls. As the amygdala as been implicated in emotional processing
(Davidson & Irwin, 1999; LeDoux, 2000; Phillips, Drevets, Rauch, & Lane, 2003), learning and
memory (Maren, 1999), and facial processing (Adolphs, Tranel, Damasio, & Damasio, 1994;
Hamann et al., 1996), this finding may account for many of the social features observed in
individuals with VCFS. Though it is tempting to conclude that the genetic anomalies associated
with this disorder mediate this neuroanatomical deviation, it has been proposed that this increase
in amygdala volume could be the result of high anxiety levels in this population (Feinstein et al.,
2002). Increased amygdala volumes have been observed in individuals with phobia and
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generalized anxiety disorders (Bellis, 2000). Dong and Greenough (2004) found that this
increased anxiety leads to experience-dependent neuronal remodeling in the amygdala, which
may contribute to its increased volume (Dong & Greenough, 2004b). Thus, it is possible that the
anxiety associated with these patients leads to the volumetric changes in the amygdala. These
neuroanatomical changes then contribute to difficulties with emotional regulation, facial
recognition, and affective style.
In addition to amygdala volume discrepancies, individuals with VCFS also have a
prefrontal cortex (PFC) that is smaller than that of age-matched, non-clinical controls (Kates et
al., 2006). The PFC has been implicated in the ability to modulate emotional stimuli and was
found to be correlated with social impairments in individuals with VCFS (Kates et al., 2006). In
particular, smaller volumes were observed in the orbitofrontal cortex relative to controls. The
orbitofrontal cortex has been implicated in the modulation of anxiety (Breiter & Rauch, 1996;
Rauch, Savage, Alpert, Fischman, & Jenike, 1997). Thus, it is possible that many of the
attachment and anxiety issues in VCFS patients may be related to abnormalities in this particular
structure.
Other sub-regions of the PFC have been implicated in social functioning. For example,
the dorsolateral PFC (DLPFC) has been shown to be involved in the regulation of affect and has
been implicated in the etiology of mood disorders such as depression (Gainotti, 1972; Robinson,
Kubos, Starr, Rao, & Price, 1984; Sackeim, Decina, & Malitz, 1982). Thus, it is conceivable
that aberrant functioning in this sub-region could mediate the mood symptoms that are frequently
observed in individuals with VCFS. That said, there is some recent evidence to suggest that
DLPFC plays only a secondary role in the etiology of mood disorders and is primarily involved
in the regulation of attentional systems and complex cognitive processing (Kobel et al., 2010;
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Seidman, Valera, & Bush, 2004; Seidman et al., 2006). Thus, though the DLPFC has historically
been implicated in the regulation of affect, contemporary research using advanced imaging
techniques suggests that the aberrant DLPFC functioning may underlie only the cognitive
deficits associated with VCFS.
In addition to the dorsolateral PFC, the ventromedial PFC (VMPFC) also has a role in
social functioning. The VMPFC has been implicated in the anticipation of future consequences
(Bechara, Damasio, Damasio, & Anderson, 1994). Specifically, individuals with damage to this
region showed an inability to accurately anticipate both positive and negative consequences.
Interestingly, individuals with damage to this region showed reduced electromodal responses
when they were presented with a risky choice relative to controls who demonstrated both
conscious recognition of the risky choice and full electromodal responses (Bechara, Damasio,
Tranel, & Damasio, 1997; Bechara, Tranel, Damasio, & Damasio, 1996). Indeed, it is possible
that much of the impulsiveness and disinhibition observed in individuals with VCFS might be
mediated by volumetric differences in this particular region. Despite this logical connection,
there has been limited research with regard to this region of the frontal cortex in individuals with
VCFS.
Taken together, these data suggest that anomalies in the prefrontal cortex mediate many
of the social deficits observed in individuals with VCFS. Furthermore, specific sub-regions
should be examined in individuals with VCFS in order to determine whether differences in these
structures mediate the observed social deficits.
Additional neuroanatomical analysis in individuals with VCFS has found discrepancies in
volume of the insular cortex (van Amelsvoort et al., 2001). In addition to this volumetric
difference, van Amelsvoort and Schmitz (2006) also noted decreased activation in right insula
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during tasks that involved facial processing (van Amelsvoort et al., 2006). The insula has been
shown to be involved in the processing of general emotions and has been implicated as one of
the etiological factors of anxiety (Rauch et al., 1995). Furthermore, it has been demonstrated
that the insular cortex plays a critical role in regulating autonomic responses accompanying
emotion. Also, the insula is a site that has been implicated in gustatory processing. It is
especially active during exposure to disgusting foods and photos of faces with an expression of
disgust, suggesting one of its functions is the recognition of distasteful stimuli (Rozin, 1997;
Young, 1997). Last, given the known input and output pathways of the insular cortex, Davidson
and Irwin (1993) concluded that the insula is likely associated with the physiological changes
that occur following autonomic activation (Davidson & Irwin, 1999). In sum, given what is
known regarding the functions of the insular cortex, the anatomical and activation abnormalities
in this structure may underlie such social deficits as withdrawal, inhibition, poor attachment, and
social anxiety. Though some speculation has been made regarding the insular cortex and social
deficits in VCFS, no one to date has directly assessed the relationship between insula and social
deficits.
In addition to the aforementioned structures, it is also possible that the STS mediates
some of the social deficits observed in individuals with VCFS. The STS has been implicated in
the development of theory of mind (ToM; Moriguchi, Ohnishi, Mori, Matsuda, & Komaki,
2007). Theory of mind is defined as the ability to attribute mental states to the self and others.
As such, it has been implicated in the development of social deficits in a number of disorders
including ASD and schizophrenia (Castelli, Frith, Happe, & Frith, 2002; Happe et al., 1996;
Ohnishi et al., 2000). Given that individuals with VCFS experience a number of social deficits
including impairments in controlling gaze, which has been hypothesized to be related to theory
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of mind (Garrett, Menon, MacKenzie, & Reiss, 2004), it is plausible that these individuals may
show volumetric differences in the STS relative to controls. Additionally, individuals with
activation deficits in this structure have difficulty maintaining appropriate social posturing as is
the case with individuals diagnosed with ASD and schizophrenia. Furthermore, the STS has
been implicated in the processing of vocal sounds (Gervais et al., 2004). Autistic individuals
showed decreased activation in this area during exposure to vocal sounds. Gervais et al. (2004)
concluded that some of the social deficits observed in ASD might be attributed to deficits in
vocal processing.
Yet another structure that has been implicated in social processing and may contribute to
the social deficits observed is the anterior cingulate cortex (ACC). The ACC has been
implicated in the ability to attend to emotional events (Posner, 1995). Additionally, Lang et al.
(1997) showed increased activity in the ACC during tasks for which attention to emotional
stimuli was required (Lane et al., 1997). When subjects were asked to attend to non-emotional
stimuli, no such activation in the ACC was recruited. It was therefore concluded that one of the
roles of the ACC was to facilitate attention to emotional stimuli. The ACC has also been
implicated in the mediation of other affective and cognitive functions (Fujiwara et al., 2007).
Specifically, the ACC helps modulate emotional responses and has been found to be an essential
component in social cognition and mentalizing (Kopelman, Andreasen, & Nopoulos, 2005).
Interestingly, volumetric differences in the ACC have been observed in schizophrenic patients
relative to controls (Kopelman et al., 2005). The smaller ACC volume has also been correlated
with specific deficits in social cognition (Fujiwara et al., 2007).
In addition to a structural level analysis of the etiology of psychopathology in individuals
with VCFS, there has been some work done at the neurochemical level. For example, the
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pathophysiological and neurochemical mechanisms that underlie depression in VCFS are
believed to be the same as for major depression. Specifically, deficits in both serotonin (5HT)
production and transmission may have been implicated in etiology of depression in this
population. Such deficits in 5HT have been observed via microdialysis procedures in mouse
models of VCFS (Tuathaigh et al., 2002). Furthermore, VCFS individuals suffering from
depression, OCD, and generalized anxiety respond well to treatment with selective-serotonin
reuptake inhibitors (SSRI’s), suggesting a deficiency in this neurotransmitter.
Similarly, neurotransmitter abnormalities have been observed in norepinephrine (NE) in
individuals with VCFS that present with mania (Papolos, Veit, Faedda, Saito, & Lachman,
1998). In addition to NE deficits, gamma-aminobutyric acid (GABA) deficiencies have also
been implicated as one of the pathophysiological mechanisms in anxiety disorders. Though there
has not been a direct examination of this neurotransmitter in individuals with VCFS who have
anxiety symptoms, anxiolytics such as benzodiazepine, a GABA agonist, are effective in
regulating anxiety levels in this population (Krishnan, 2005)
Additionally, cortisol and the subsequent production of glucocorticoids has been
implicated in anxiety (Hoehn-Saric, McLeod, Lee, & Zimmerli, 1991), depression (Vythilingam
et al., 2004), and some features of social impairment (Corbett et al., 2009) in related populations.
Anomalous cortisol levels have not yet been demonstrated in this population, but have been
shown in children with ASD (Curin et al., 2003; Naber et al., 2007; Richdale & Prior, 1992) and
schizophrenia (Carroll, 1976; Walder, Walker, & Lewine, 2000), two disorders commonly
associated with VCFS. The remainder of this literature review will emphasize the role of cortisol
in the development of various psychopathology and social impairment.
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Physiological Description of the Human Stress Response
It is a widely disseminated finding that there are two distinct types of stress. There is
short-term, brief stress, which is generally thought to be adaptive, and necessary to sustaining
and energizing the fight or flight response. This is the type of stress associated with brief
sympathetic activation and is one of the autonomic physiological mechanisms that is said to have
facilitated our survival throughout evolution. The stress response is quite complex, requiring the
integration between numerous structures, hormones, and systems throughout the body (Sapolsky,
1996). First, a stressor occurs. This, in the short-term, usually involves some immediate danger
that requires the body to engage in action. Following recognition of the stressor, a cascade of
events occurs. Initially, there is a brief release of catecholamines. Specifically, epinephrine and
norepinephrine are secreted by nerve cells approximately 2 seconds following exposure to the
stressor (Sapolsky, Romero, & Munck, 2000). Examination using microdialysis has found that
stressful situations are associated with higher concentrations of norepinephrine in the
hypothalamus, frontal cortex, and lateral basal forebrain (Cenci, Kalen, Mandel, & Bjoerklund,
1992; Yokoo et al., 1990). Approximately 10 seconds later, the hypothalamus receives signals to
release corticotropin releasing hormone (CRH) into general circulation (Horowitz, 1986). CRH
is also released into the brain where it acts as a neuromodulator and neurotransmitter. This
means that CRH can have direct impact on the regulation of simple and complex functions of the
nervous system. For example, CRH has been shown to impact periaqueductal gray matter, the
locus coeruleus, and the central nucleus of the amygdala (Moriceau, Roth, Okotoghaide, &
Sullivan, 2004). The infusion of CRH into the central nervous system has behavioral
consequences. Interestingly, these behavioral consequences mirror those associated with
exposure to aversive stimuli. For example, injections of CRH into the central nervous system
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lead to an increase in neophobia in rats (Britton, Koob, Rivier, & Vale, 1982). Additionally,
CRH infusions to the central nervous system have been shown to facilitate acquisition of a
classically conditioned fear response (Cole & Koob, 1988). Alternatively, introduction of CRH
antagonists via intracerebroventricular injection decreases the experience of anxiety that is
caused by an array of stressful situations (Kalin, Sherman, & Takahashi, 1988). Thus, the stress
response does indeed have an impact on structures and circuits of the CNS.
Next, CRH bind to receptors on the pituitary gland stimulating the release of adrenocorticotropic hormone (ACTH; Kvetnansky et al., 1995). Following these changes, the
hypothalamus decreases production and release of gonadotropin releasing hormone (GnRH) with
subsequent decreases in pituitary gonadotropins (Sapolsky et al., 2000). This initial
physiological response to immediate stressors occurs quickly, with only a small delay between
endocrine up-regulation and activation of target tissues via a second messenger cascade. It is this
initial physiological response to environmental threats that is responsible for changes associated
with sympathetic activation, which includes pupil dilation, salivation inhibition, sweating
stimulation, vasoconstriction, inhibition of digestion, and so on (Carlson, 2004). This initial
response to a stressor is brief, usually terminating within an hour (Sapolsky et al., 2000).
The next step in the physiological stress response involves the release of glucocorticoids,
in particular cortisol. Cortisol is released when ACTH, released by the pituitary gland, enters the
general circulation and binds to the adrenal cortex stimulating glucocorticoid release. Under
normal circumstances of low-grade stress, glucocorticoids facilitate the degradation of proteins
and the subsequent conversion to glucose preparing nutrients for the organism to utilize.
Additionally, the hormone helps increase blood flow, thereby increasing blood pressure. Also,
glucocorticoids stimulate behavioral responsiveness in numerous biological systems (Carlson,
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2004). Overall, glucocorticoids have numerous effects throughout the brain due to the ubiquity
of glucocorticoid receptors throughout body tissues and brain.
These effects in the short term have evolved to ensure organismal survival. In fact,
individuals with damage to their adrenal cortex are prone to death when encountering stressful
stimuli and need to be administered exogenous glucocorticoids (Tyrell & Baxter, 1981). That
said, the stress response evolved to manage short-term, immediate, and identifiable stressors. In
contemporary society, stressors exist that are long-term and ambiguous. For example, financial
concerns, work-related stress, family stressors, and stress associated with physical and emotional
trauma are just a few types of stressors that activate the stress response frequently over long
periods of time. Long-term exposure to stressful situations can significantly impact overall
physical health and functioning. For example, holocaust survivors, particularly those who lived
in concentration camps, have significantly poorer health in later stages of life than individuals
not exposed to such extremely stressful conditions (Cohen, 1953). Further evidence of the
deleterious impact of long-term stress on overall physical health is seen in subway drivers and
air-traffic controllers. According to Theorell et al. (1992), subway drivers who were involved in
accidents where individuals were maimed or killed developed more illnesses in several months
following the incident than individuals not exposed to significant stressors (Theorell et al., 1992).
Air-traffic controllers are also prone to stress-related health conditions and demonstrate a higher
incidence of high blood pressure, ulcers, and diabetes (Cobb & Rose, 1973).
Physical Deficits Associated With Long-Term Stress Exposure
There is little debate as to the etiology of health deficits following prolonged exposure to
stress. In a seminal work, Hans Selye (1976), implicated glucocorticoids as the primary cause of
the deleterious health consequences of prolonged stress exposure (Selye, 1976). Subsequent
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analyses of the effect of glucocorticoids on stress-related health decline have demonstrated that
glucocorticoids can impact a variety of systems. In particular, prolonged glucocorticoid
exposure has been implicated in increased blood pressure, damage to muscle tissue, diabetes,
infertility, inhibition of growth, inhibition of the inflammatory response, and suppression of the
immune system (Carlson, 2004).
Secondary effects of high blood pressure include increased risk of heart attack and stroke.
According to DeVries et al. (2001), social stressors increase the risk of stroke and subsequent
apoptosis-related damage by suppressing bcl-2 expression (DeVries et al., 2001). The bcl-2 gene
is involved in the prevention of cellular necrosis and apoptosis. Social stressors, particularly
those involving chronic intimidation, have a pronounced effect on bcl-2 protein production,
increasing susceptibility to stroke and more severe damage and tissue loss during stroke. Thus,
stress both increases the likelihood of a stroke by increasing blood pressure and then makes the
impact of the stroke more damaging by decreasing expression of neural protective proteins.
As mentioned previously, stress can impact physical growth and development. In
children, exposure to long-term stress can lead to decreased attainment in height and failure to
thrive. The mechanism for decreased stature and body weight is complicated and influenced by
numerous factors. However, on the simplest level, long-term exposure to glucocorticoids leads
to suppression of the release of growth hormones leading to background growth failure without
organic etiology (Skuse, Albanese, Stanhope, Gilmour, & Voss, 1996). Interestingly, once the
children were removed from familial stressors, spontaneous “catch-up” occurred and growth
hormonal levels normalized. Thus, childhood stress has a significant impact on growth and
development.
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Glucocorticoids have also been shown to inhibit the positive inflammatory response,
resulting in increased healing time and permanent tissue damage and infection following injury.
Some of the deleterious effects of stress were demonstrated by examining the healing rate of
wounds on caregivers of patients suffering from Alzheimer’s disease relative to controls
(Kiecolt-Glaser, Marucha, Malarkey, Mercado, & Glaser, 1995). Measures of wound
size/diameter and application of hydrogen peroxide indicated that care-giving related stress
delays wound healing. As mentioned previously, mechanistically, this occurs via suppression of
the inflammatory response.
There are other physical problems that occur in response to long-term exposure to stress;
however, these are beyond the scope of this discussion. It is sufficient to conclude that
glucocorticoids can impact nearly every system of the body as a result of diffuse receptor
distribution.
Impact of Stress on Cognition
In addition to the deleterious effects of long-term glucocorticoid exposure on physical
health, there are negative cognitive consequences to long term stress exposure. There are
multiple cognitive consequences of stress including memory impairment, compromised learning
ability, executive dysfunction, and attentional impairments.
Memory changes are one of the most prominent changes observed in response to longterm stress exposure. On a specific assessment of declarative memory performance in the
elderly, researchers observed that exposure to a stressful task (public speaking) has a more
negative impact on memory than exposure to a benign task (Lupien et al., 1997). Additionally,
there seems to be some specificity with regard to the type of memory impaired during prolonged
cortisol exposure. According to Newcomer et al. (1999), verbal declarative memory was
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differentially impacted when compared with performance on nonverbal memory measures
following exposure to long-term stress (Newcomer et al., 1999). Thus, though memory
impairment is a common finding in examinations of the effects of long-term stress exposure, it
appears there is some preservation of nonverbal memory abilities.
Not only does long-term psychological stress have an impact on encoding and retrieval, it
also has an impact on memory strategies (Johnsen & Asbjornsen, 2009). According to
researchers, individuals with Post-Traumatic Stress Disorder (PTSD), a disorder associated with
high-resting cortisol levels, have difficulty employing effective list-learning strategies as
evidenced by poor performance on the California Verbal Learning Test-II (CVLT-II).
Specifically, individuals did not use semantic clustering strategies, but rather employed only a
recency strategy during recall trials. According to the authors, this reflected an underlying
deficit in the formation of effective encoding strategies. Thus, not only is there evidence of
mechanistic deficit associated with encoding and retrieval, there are also deficits in the way the
individual organizes information before encoding.
There are numerous hypotheses regarding the mechanism of memory impairment
observed in individuals exposed to long-term stress and glucocorticoid exposure. One generally
accepted mechanism is hippocampal atrophy. The hippocampus is an essential structure in
learning and memory (Carlson, 2004). According to Sapolsky and McEwan (1995), long-term
exposure to glucocorticoids damages neurons located in field CA1 of the hippocampus. Cellular
atrophy occurs because corticosteroids prevent the entry of glucose into the cell as well as the
reuptake of glutamate, two essential features for survival of the cell (McEwen & Sapolsky,
1995). Furthermore, due to the decreased reuptake of glutamate, there are excessive amounts of
glutamate outside of the cell body. This extracellular glutamate opens an inordinate amount of
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calcium channels leading to excitotoxicity and cell death. The cell death in this structure is so
pronounced that volumetric changes can be observed using imaging technology (Gurvits et al.,
1996). In combat exposed veterans with symptoms of PTSD, a 20 percent reduction in
hippocampal volume was observed. Interestingly, the amount of tissue loss was positively
correlated with the amount of combat exposure. A similar finding was observed in children who
were the victims of child abuse. In this population, hippocampal atrophy has been implicated in
the formation of false memories and inability to recall specific details of the abuse event
(Bremner, Krystal, Southwick, & Charney, 1995).
The hippocampus plays another important function in the stress response by operating as
a stop gap for stress hormone release (Sapolsky et al., 2000). That is, the hippocampus is part of
a negative feedback loop that disengages the stress response. This mechanism works perfectly
under conditions of brief exposure to stress. However, as exposure to stress hormones becomes
prolonged, the hippocampus becomes more atrophied. As the atrophy progresses, the structure
loses its ability to help regulate the stress response via biofeedback, and the stress hormones are
able to circulate unimpeded throughout the various systems of the body. Thus, prolonged stress
exposure leads to the inability to further regulate the stress response, which leads to more
hippocampal damage, more memory impairment, and even less ability to regulate the stress
hormone. In other words, the system gets converted from a system regulated by negative
feedback to one that resembles a feed forward process.
The impact of stress on memory and learning is not entirely mediated by the impact of
glucocorticoids and the hippocampus. The amygdala, a structure implicated in the coordination
of stress behaviors and modulation of memory consolidation, also plays a role in the deleterious
effects of the stress response (Kim, Lee, Han, & Packard, 2001). In an experiment examining
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the role of the amygdala in stress-related memory and learning impairments, researchers
observed that rats with lesions to the amygdala did not show learning deficits during
performance of the Morris Water Maze following exposure to stress. Thus, elevated
glucocorticoid levels alone are not sufficient to induce cognitive impairment; other structures
within the limbic system facilitate the physiological and behavioral response to stress.
Psychological Problems Associated with Long-Term Exposure to Glucocorticoids
There have been numerous psychological disorders mediated by or exacerbated by longterm exposure to stress. Indeed, PTSD is one disorder characterized by stress-related atrophy to
the hippocampus (Gurvits et al., 1996). Interestingly, individuals with PTSD do not show
elevated cortisol secretion. In fact, they have a tendency to show decreased production and
release of cortisol (Yehuda, 2001). Despite this decrease in cortisol production, individuals show
an elevated stress response because of an increase in stress hormone receptor proliferation and
sensitivity. That is, there are more receptors with increased sensitivity for the stress hormone. As
such, there is less cortisol released by the adrenal cortex, but the negative effects are still
observed due to increased binding efficiency.
In addition to PTSD, Generalized Anxiety Disorder (GAD) and Panic Disorder have also
been associated with increased cortisol levels (Graeff, 2007; Hoehn-Saric et al., 1991). The
amygdala is a neurological structure directly implicated in anxiety and depression.
Corticosteroids have been shown to increase the CRH mRNA expression at the central nucleus
of the amygdala (Merali, Anisman, James, Kent, & Schulkin, 2008). This expression increases
activation in the amygdala, leading to a potentiation of the fear response and symptoms of
anxiety. Thus, cortisol can affect the development of anxiolytic symptoms via promotion of
CRH release in the central nucleus of the amygdala.

28

Mood disorders are also mediated by increased levels of corticosteroids. A more recent
conceptualization of the neurobiological etiology of some forms of depression posits that a
decrease in neurogenesis has a significant impact on mood stability. Neurogenesis is defined as
the birth of new neurons (Carlson, 2004). To date, there are only a few sites in the brain that
have been shown to be capable of producing new neurons. One of these structures is the
hippocampus; the same region where atrophy takes place following prolonged exposure to
glucocorticoids. Neurogenesis is facilitated by neurotrophic growth factors. Long-term cortisol
exposure can inhibit production of neurotrophic factors such as brain-derived neurotrophic factor
(BDNF). This results in the inhibition of cell proliferation and integration into existing
neurological circuits. Such decreases of cell proliferation have been associated with mood
impairment in individuals with depression (Huang & Herbert, 2006). Thus, stress can lead to the
decrease of neurogenesis, which contributes to the development of depression. Further evidence
for the role of neurogenesis in the regulation of mood was demonstrated in an experiment
assessing the mechanism of efficacy for fluoxetine, a selective serotonin reuptake inhibitor
(SSRI) commonly used in the treatment of depression and anxiety. Findings suggest that
fluoxetine facilitates the proliferation of progenitor cells, the precursors to hippocampal cells, in
the dentate gyrus (Huang & Herbert, 2006). Following cellular proliferation, cognitive and
mood symptoms associated with depression are alleviated, usually within 3 weeks, the same
length of time it takes new cells to become integrated into neuronal circuits. In summary,
cortisol inhibits neurogenesis, an integral process in the maintenance of cognitive functioning
and mood stability. Moreover, it is this inhibition of neurogenesis and active degradation of
neural tissues that may account for many of the aforementioned neuroanatomical anomalies
found in individuals with VCFS.
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To conclude, increased cortisol levels may contribute significantly to the
psychopathology and cognitive deficits observed in individuals with VCFS. To date, there have
been no studies examining the direct impact of cortisol on psychopathology in this particular
population. However, given evidence from other populations, it is reasonable to conclude that
some of the observed short-term memory deficits, mood impairment, anxiety, and psychotic
symptoms may be mediated or exacerbated by the presence of high baseline cortisol levels in
individuals with VCFS.
Specific Social Deficits Related to Abnormal Cortisol Levels
As previously mentioned, cortisol and the subsequent production of glucocorticoids has
been implicated in anxiety (Hoehn-Saric et al., 1991), depression (Vythilingam et al., 2004), and
social impairment (Corbett et al., 2009) in related populations. To date, anomalous cortisol
levels have not yet been demonstrated in this population but have been shown in children with
ASD (Curin et al., 2003; Naber et al., 2007; Richdale & Prior, 1992) and schizophrenia (Carroll,
1976; Walder et al., 2000), two disorders commonly associated with VCFS. Specifically, in
children with ASD, higher ACTH levels were observed relative to control children, suggesting a
significant disruption in the HPA axis (Curin et al., 2003). Additionally, higher cortisol levels in
children with ASD were associated with greater sensory sensitivity and social stress (Corbett et
al., 2009). Finally, cortisol levels in children with ASD were correlated with parental
attachment. Aberrant cortisol levels in children with ASD were related to poorer attachment
ratings as measured by the Strange Situation Procedure (SSP; Naber et al., 2007). Moreover, the
severity of autistic symptoms was also correlated with baseline cortisol levels. Thus, given what
is known about this hormone in children with ASD, it is conceivable that cortisol may have both
a direct or indirect impact on overall social competency in VCFS, a population that exhibits
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considerable social impairment. Indeed, additional research is necessary to determine cortisol’s
role in regulating mood, anxiety, and pro-social behavior in children with VCFS. From the scant
research on the impact of cortisol in children with ASD, it is difficult to ascertain whether
elevated cortisol levels are due to exposure to environmental stress or physiological
predisposition to dysregulation of the HPA axis. However, in individuals with VCFS, previous
research has demonstrated enlargement in structures involved in glucocorticoid regulation (Kates
et al., 2006). That said, enlargement of the amygdala in this population does not rule out an
environmental explanation of elevated stress hormones. Indeed, neuroplasticity occurs
frequently in response to environmental contingencies (Dong & Greenough, 2004a). As
mentioned previously, Dong and Greenough (2004) found that increased exposure to anxietyprovoking situations lead to experience-dependent neuronal remodeling in the amygdala, which
may contribute to its increased volume (Dong & Greenough, 2004b). Thus, it is possible that the
anxiety associated with these patients leads to the volumetric changes in the amygdala and the
subsequent release of glucocorticoids. Thus, it is difficult to hypothesize whether environmental
circumstances or physiological predispositions to HPA hyperactivation contribute to
hypothesized cortisol elevations in individuals with VCFS and related disorders. Thus, it is
important to note that one aim of the current study is not to provide evidence for the etiology of
elevated cortisol levels in children with VCFS, but rather to examine the relationship between
cortisol and measures of memory, social functioning, and adaptive functioning.
To conclude, there is considerable evidence from a variety of clinical groups that aberrant
cortisol levels have an impact on neuroanatomical architecture, physical symptomatology,
psychopathology, cognitive functioning, and social competency. Given that children with VCFS
display behaviors and symptomatology similar to other groups known to have disruptions in
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cortisol levels, it is reasonable to hypothesize that a similar cortisol disruption would be observed
in this population as well. Moreover, the poor regulation of cortisol would be related to specific
cognitive and social deficits in children with VCFS.
An understanding of the relationship between cortisol levels, cognitive impairment, and
social competency is important for several reasons.
First, understanding causal mechanisms of social and cognitive impairment can help
facilitate more accurate theories of the etiology of symptoms associated with
neurodevelopmental disorders. Moreover, understanding of the relationship between aberrant
cortisol levels and social and cognitive impairment can contribute to our current understanding
of normal brain-behavior relationships.
Second, understanding the relationship between cortisol and various symptomatologies
can inform treatment. That is, cortisol levels and rhythms can be normalized pharmacologically
and behaviorally. Evidence for pharmacological regulation of glucocorticoids is observed in
Cushing’s patients who receive treatment with glucocorticoid antagonists such as ketoconazole
(Nizoral), mitotane (Lysodren), and metyrapone (Metopirone; Carlson, 2004). Following
treatment, many of the emotional and cognitive symptoms associated with Cushing’s are reduced
(Sonino & Fava, 1998). Behaviorally, the deleterious impact of cortisol on biological systems
has been successfully treated with behavioral activation procedures. This process works via the
promotion of neurotrophic factors and the facilitation of neurogenesis, which leads to increased
hippocampal volumes and increased regulation of glucocorticoid release. Though there are few
studies to date that have directly examined the role of behavioral activation therapy on the
cortisol response in children and adults with VCFS, it is likely that increased exposure to
reinforcing elements of the environment leads to an increase in neurogenesis, which helps to
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alleviate the cognitive and mood symptoms associated with depression. For example, one study
found that “rewarding” behaviors such as running, eating, and sexual activity all increase
neurogenesis and function as antidepressants in animal models of depression (Brene et al., 2007).
Thus, to date there has been research implicating that behavioral activation serves to alleviate
depressive symptoms through the increase of neurogenesis and normalization of HPA
functioning. Therefore, further understanding of hormonal regulation in individuals with VCFS
can inform treatment recommendations and protocols and lead to enhanced prognosis.
Third, understanding of the relationship between neurohormones and behavior can lead to
the development of physiological biomarkers that can facilitate determinations of severity and
prognosis. In addition to imaging and genetic biomarkers, neurohormonal assays are frequently
being employed as biomarkers indicative of psychopathology (Bartels, de Geus, Kirschbaum,
Sluyter, & Boomsma, 2003). Recently, cortisol has been implicated in the susceptibility of
individuals to Post-Traumatic Stress Disorder (PTSD; Bachmann et al., 2005; Yehuda, 1999),
developmental deficits in children with ASD (Curin et al., 2003), and the etiology of
schizophrenia and affective disorders (Carroll, 1976; Gerra et al., 2008). That said, to date there
have been no studies examining the relationship between baseline cortisol levels and the social
and cognitive deficits observed in VCFS. Indeed, an examination of cortisol in this population
may help predict the type of deficits expected and may facilitate early, more specific
intervention. That is, currently, the presentation of symptomatology in VCFS is highly variable.
Research using neurohormonal assessments may unveil relationships between specific
symptomatology and cortisol levels, which may help practitioners more accurately predict the
presence or absence of symptoms and therefore design more efficient interventions.
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In summary, there are multiple reasons for examining the role of cortisol in the
development of cognitive and social impairment in children with neurodevelopmental disorders.
Moreover, children with VCFS due to their significant deficits in social competency and
comorbid cognitive impairment are an ideal group to study neurohormonal contributions to
pathology given their specific range of deficits.
Hypotheses
Specific Aim 1 was to determine if there are differences between baseline cortisol levels
in individuals with VCFS relative to controls. Given the role that cortisol plays in emotional
processing and the experience of anxiety and the fact that children with VCFS have increased
anxiety likely due to their neuronal architecture, cognitive interpretation of stressful events, and
as they are less emotionally stable, it was hypothesized that VCFS individuals will have a
significantly higher baseline cortisol levels relative to controls.
Specific Aim 2 was to determine whether individuals with VCFS perform significantly
poorer on tests of memory and learning relative to controls. Given existing literature regarding
cognitive functioning in individuals with VCFS, it was hypothesized that individuals with VCFS
would exhibit significantly lower performance on measures of memory and learning.
Specifically, individuals with VCFS would exhibit specific deficits in general memory ability,
working memory ability, and attention and concentration as measured by the Wide Range
Assessment of Memory and Learning (WRAML-2).
Specific Aim 3 was to determine if there are any differences in the level of social
functioning between individuals with VCFS and controls. Given the significant social
impairment commonly reported in studies involving children with VCFS, it was hypothesized
that children with VCFS would perform significantly worse on measures of social functioning.
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Specifically, ratings of social competency would be lower while ratings of social problems,
thought problems, and anxiety/depression as measured by the CBCL would be significantly
higher in children with VCFS. Additionally, individuals with VCFS would be rated significantly
lower on the social scale and communication scale of ABAS-II. Finally, Children with VCFS
would exhibit significantly higher levels of social anxiety and total anxiety as measured by the
RCMAS-2 relative to controls.
Specific Aim 4 was to assess the relationships between cortisol levels and memory and
social functioning in individuals with VCFS. Given the impact that elevated cortisol levels have
on neurological structures supporting working memory, long-term memory,
attention/concentration, and nonverbal memory storage, it was predicted that cortisol level would
be negatively correlated with measures of cognitive performance in these domains. Additionally,
there is evidence in the PDD literature suggesting that an augmented physiological stress
response underlies many of the social competency issues associated with ASD and other PDD
(Curin et al., 2003; Naber et al., 2007). As a result of the significant anxiety observed in
individuals with VCFS, it was hypothesized that the cortisol levels would be correlated with
measures of social competency and social functioning. Specifically, it was hypothesized that
cortisol levels would be negatively associated with social competency as measured by the CBCL.
Additionally, it was predicted that a positive association between cortisol levels and the anxious,
depressed, social problems, and thought problems subscales of the CBCL would be observed.
Moreover, a negative association would be observed between cortisol levels and the socialization
and communication subscales of the ABAS-II. Finally, a positive association would be observed
between the social anxiety scale and total anxiety of the RCMAS-2.
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Measures
Child Behavior Checklist (CBCL): The CBCL is a standardized, parent-report measure
of children’s (ages 4-18) behavior problems and competencies. The problem portion of the
measure consists of 118 specific problem items that compose the 9 subscales (Withdrawn = 9
items, Somatic Complaints = 3 items, Anxious/Depressed = 14 items, Social Problems = 8 items,
Thought Problems = 7 items, Attention Problems = 11 items, Delinquent Behavior = 13 items,
Aggressive Behavior = 20 items, and Other Problems including Sex Problems = 33 items). The
competency portion of the measure contains 20 items that compose the 3 subscales (Activities =
5 items, Social = 6, School = 4 items, and Other = 5 open items not scored in the profile).
CBCL Subscales and Competency: For the problem scale, items are scored on a 3-point
Likert-type response scale with the following anchors: 0 = Not True, 1 = Somewhat or
Sometimes True, 2 = Very True or Often True. Problem Scale scores can range from 0 to 236.
Raw scores are converted into T scores for clinical analysis. A high total problem score (>T =
70) indicates that the child is experiencing a clinically significant level of disordered behavior.
Furthermore, a child can have a low total problem score but have an elevated sub-scale (>T = 70)
indicating significant behavior problems in the specific domain. For the competency scale, items
are scored on a mix of three (0, 1, 2), and four (0, 1, 2, 3, 4) option Likert-type items as well as
number of dichotomously scored items (0 = no, 1 = yes). Competency Scale scores can range
from 0 to 23. The raw scores are then converted into T scores for clinical analysis. High total
competency scores indicate a high level of competence. Low total competency scores (<T = 30)
indicate a low level of overall competence. Furthermore, a child can have relatively high
competency scores but score low in one particular domain, indicating a lack of competency in
the corresponding subscale.
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Problem scales for the CBCL were derived from an item-level principal components
analysis. Thus, the composition of items for each subscale is based on internal consistency of a
group of items. The total problems scale has good overall internal consistency (α = .96). The
problem subscales also have acceptable internal consistencies (Withdrawn, α = .80; Somatic, α =
.72; Anxious/Depressed, α = .86; Social Problems, α = .76; Thought Problems, α = .68; Attention
Problems, α = .83; Delinquent Behavior, α = .83; Aggressive Behavior, α = .92). The
competency scales were derived in a similar fashion using principal component analyses. The
total competency scale has less overall internal consistency than the total problem score (α =
.64). Similarly, each competence subscale has lower internal consistency than the problem
subscales (Activities, α = .42; Social, α = .60; School, α = .61). This lower internal reliability is
likely due to the small number of items in each competency subscale relative to the problem
subscales.
In addition to adequate internal consistency, the CBCL has high inter-interviewer
reliability. Scores from three interviewers of 723 children were compared. The overall intraclass correlation coefficient (ICC) for problem items was .96. The overall ICC for the
competence items was .93. Thus, inter-interviewer reliability is high.
The CBCL also has a high inter-parent reliability according to Cohen’s (1988) criteria.
The overall mean r for the total problems scale was .76. Each problem subscale also had a
significant mean r indicating high inter-parent agreement (Withdrawn, r = .66; Somatic
Complaints, r = .52; Anxious/Depressed, r = .66; Social Problems, r = .77; Thought Problems, r
= .48; Attention Problems, r = .79; Delinquent Behavior, r = .78; Aggressive Behavior, r = .77;
Sex Problems, r = .52). Similarly, the overall total competence scale has high inter-parent
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reliability indicated by a mean r of .79. Each competence subscale also had a significant mean r
indicating high inter-parent agreement (Activities, r = .59; Social, r = .73; School, r = .87).
Furthermore, the CBCL has high test-retest reliability across a seven-day interval. Scores
from 80 subjects were used in the temporal stability analysis. The overall total competence scale
had a mean r (averaged across all competency subscale scores) of .89. Each problem subscale
also had a significant test-retest reliability (Withdrawn, r = .82; Somatic Complaints, r = .95;
Anxious/Depressed, r = .86; Social Problems, r = .87; Thought Problems, r = .82; Attention
Problems, r = .90; Delinquent Behavior, r = .86; Aggressive Behavior, r = .91; Sex Problems, r =
.83). Similarly, the competence scale had high overall test-retest reliability in the analysis with a
mean r of .87. Each competence subscale also had a significant mean r indicating high test-retest
reliability (Activities, r = .80; Social, r =.70; School, r =.92).
In sum, the CBCL has high internal consistency, scores are stable over a brief time frame
(one week), and there is acceptable inter-rater agreement for both interviewers and parents.
Collectively, these data support the use of the CBCL in this experiment.
CBCL Validity: The problem scale of the CBCL has high convergent validity evidenced
by high correlations with other behavioral measures including the Connor’s Parent Questionnaire
(1973) and the Quay-Peterson Revised Behavior Checklist (1983). The correlation between the
total problem scale on the CBCL and the Connors Parent Questionnaire is .82 (p < .0001). The
problem subscales were also highly correlated with related subscales on the Connors Parent
Questionnaire (Somatic Complaints-Psychosomatic r =.70; Anxious/Depressed-Anxiety, r = .67;
Attention Problems-Impulsivity/Hyperactivity, r =.59; Delinquent Behavior-Antisocial, r = .77;
Aggressive Behavior-Conduct Problem, r = .86). The correlation between the total problem
scale on the CBCL and Quay-Peterson Revised Behavior Checklist was r = .81 (p < .0001). The

38

problem subscales were also highly correlated with related subscales on the Quay-Peterson
Revised Behavior Checklist (Withdrawn-Anxiety, r = .66, Anxious/Depressed-Anxiety, r =.78;
Thought Problems-Psychotic, r =.64; Attention Problems-Attention Problems, r = .77;
Delinquent Behavior-Socialized Aggression, r = .59; Aggressive Behavior-Conduct Disorder, r
= .88). Thus, the CBCL is highly correlated with measures and subscales purporting to measure
similar constructs. Statistics for discriminate validity were unavailable for this particular
measure.
The criterion-related validity of the CBCL is supported by the fact that the CBCL
quantitative scale can discriminate between referred and non-referred children after removing the
effects of demographics. The overall total problem score accounts for 32% of the variance in
referral status. Most problem subscales also account for a significant percentage of the variance
in referral status (Withdrawn= 16%; Anxious/Depressed= 21%; Social Problems= 24%; Though
Problems= 16%; Attention Problems= 31%; Delinquent Behavior r = 21%; Aggressive Behavior
r = 24%). Similarly, the overall total competence score accounts for a significant amount of
variance in referral status (26%). Additionally, two of the three subscales account for a
significant amount of the variance in referral status (Social= 18%; School= 37%). Thus, because
the CBCL can discriminate between clinical samples and non-clinical samples, it is said to have
a high measure of criterion-related validity. In further support of criterion-related validity,
clinical cut points on the scale scores were shown to discriminate between referred and nonreferred children (Achenbach, 1991).
In sum, the CBCL has content validity, convergent validity, and criterion-related validity,
which support construct validity. Thus, it use in this particular experiment to assess the
behavioral problems and social competency of individuals with VCFS is justified. Overall, this
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measure was chosen for its internal and external validity as well as its ability to capture a wide
array of pathological behaviors. Additionally, there is a subscale on this measure specifically
devoted to social competency, a construct that is of particular interest in this study and not well
established on other measures of social functioning.
ABAS-II: The ABAS-II (Parent Form; Ages 5-21) is a diagnostic assessment measuring
adaptive behaviors associated with daily functioning in both domestic and external social
environments. It consists of 232 items that compose 10 primary skill areas: Communication,
Community Use, Functional Academics, Home living, Health and Safety, Leisure, Self-Care,
Self-Direction, Social, and Work. Item responses are selected based on a 4-point Likert scale
with the following anchors: 0= Is Not Able; 1= Never or Almost Never When Needed; 2=
Sometimes When Needed; 3= Always or Almost Always When Needed. Overall, higher standard
scores on the ABAS-II denote greater competency in a specific domain. Standard scores are
based on a normal curve distribution.
Items on the ABAS-II were developed using pilot and tryout studies involving 1045
parents. Item statistics, differential item functioning, item guessing rate, item bias, skill area
reliability, validity, clarity of instructions, and clinical usefulness were determined based on pilot
data. Standardization was done using a representative sample stratified according to data from
the 2000 census. Eleven age groups spanning ages 5-21 were utilized for standardization. An
equal number of males and females were used in each of the 11 age groups. Racial groupings
were stratified into the 11 age groups according to the proportions indicated by the census data.
Finally, geographic regions were included into the age groups proportionally as indicated by the
census data. Some of the relevant data will be reported here. For the complete statistical profile
and item analyses see Harrison & Oakland (2003).
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ABAS-II Reliability: With regard to internal consistency, coefficient alpha was
calculated to determine inter-item relationships. Average reliability coefficients for the adaptive
domains across the six standardization samples are between .80 and .97, indicating that there is a
high degree of internal consistency for the measure.
In addition to a high degree of internal consistency, the ABAS-II also has a low standard
error of measurement (SEM). Average SEM ranges from .86-1.38 for the skill areas, suggesting
low overall measurement error for each of the domains assessed in the scale.
Test-retest reliability was examined by having parents rate the same child on two separate
occasions with approximately 12 days between each rating. Correlations ranged from .84-.93 for
skill areas, suggesting that the measure is reliable at two individual time points and that the testretest reliability is adequate for this experiment.
Inter-rater reliability and cross-form consistency were calculated with Pearson’s productmoment correlation. Inter-rater reliability correlations ranged from .76-.93, suggesting adequate
consistency across raters. Cross-form consistency ranged from .51-.81, which is relatively high
given that the ratings were taken in two distinct forms on two separate individuals settings.
In summary, the ABAS-II has good reliability characteristics that should facilitate the
acquisition of consistent data in this experiment.
ABAS-II Validity: Content validity of the ABAS-II is supported by inclusion of
theoretical skill areas purported to measure adaptive behavior that have been shown to be
important in the development of independent living and social skills in previous research studies
(Harrison & Oakland, 2003). Specifically, the 10 skill areas included in the measure have been
shown in previous literature to be highly correlated with global functioning and age-appropriate
activities of daily living. Additionally, in order to support content validity, items were selected
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according to four principles. First, items selected needed to be clinically relevant and applicable
to practice. Second, total item number was to be high enough to support reliability but low
enough to promote respondent completion without interference from fatigue. Third, items
included needed to be directly observable. Fourth, psychometric properties (previously reported)
should be adequate for an observer-report measure. These guiding principles combined with use
of theory-based skill area inclusion support content validity in this measure.
In addition to theory-based item selection, confirmatory factor analysis using the TuckerLewis Index (TLI) was conducted in order to ensure the content validity of the measure. A onefactor model was found to fit the data best (TLI= .91), suggesting that the 10 skill areas underlie
a global adaptive ability index. In other words, the skills areas do in fact measure a unified
construct of global adaptive functioning and therefore items in each of these skill areas are
sufficiently measuring the construct.
The ABAS-II also has a high degree of convergence with scales purporting to measure
general adaptive ability. Specifically, individual and global scales of the ABAS-II are highly
correlated with related scales of the Vineland Adaptive Behavior Scale (VABS). Specifically,
correlations on related skill areas ranged from .69 to .84, suggesting a high degree of convergent
validity. Moreover, the ABAS-II has a weak relationship with other measures of behavior that
serve as behavior screens or indicators of severe impairment. For example, correlation of the
ABAS-II global composite with the Scales of Independent Behavior- Revised (SIB-R) broad
independence score, a brief screen of independent daily activities, was fairly low (r = .18).
Taken together, these data suggest that the ABAS-II has adequate convergent and discriminant
validity.
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Finally, the ABAS-II has adequate clinical validity as well. That is, it can distinguish
well between clinical groups and normal controls. A reporting of data from these clinical groups
is beyond the scope of this paper. However, it is important to note that children with ASD and
other social deficits were reported as being considerably worse in the social domain relative to
normal controls. Specifically, they were rated 36.25 points lower on average in this particular
skill domain relative to controls (p< .01). In summary, the scale is sensitive with regard to
differentiation of clinical populations. Moreover, the items composing the social skills scale are
clearly sufficient to detect social deficits and therefore, its use in this particular experiment is
justified.
To conclude, the ABAS-II exhibits both adequate reliability as evidenced by the high
degree of internal consistency, test-retest reliability, and inter-rater reliability. Additionally,
construct validity and overall validity are supported with evidence of content validity,
convergent validity, discriminant validity, and clinical validity. As such, the test is an adequate
measure of key aspects of social functioning and other activities of daily living.
WRAML-2: The WRAML-2 is a comprehensive assessment of memory and learning
designed to assess memory abilities following traumatic brain injury, neurological insult, trauma,
and other psychological issues (Sheslow & Adams, 2003). The battery takes less than 1 hour to
administer in most cases and therefore is ideal for capturing global memory abilities in children
with shorter attention spans or other disability. Also, due to its relative brevity the measure is of
good use as a memory screener. The WRAML-2 is normalized for individuals age 8 to adult
and therefore is ideal for studies involving both children and young adults. Generally, the
WRAML assesses immediate and delayed recall, verbal memory, visual memory, and working
memory. Primary indices include General Memory, Verbal Memory, Visual Memory, and
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Attention-Concentration. These indices are composed of 17 subtests assessing different domains
of cognitive functioning: Story Memory, Verbal Learning, Design Memory, Picture Memory,
Finger Windows, Number/Letter Sequencing, Sentence Memory, Sound Symbol Test, Verbal
Working Memory, Symbolic Working Memory, Story Memory, Verbal Learning Delay Recall,
Sound Symbol Delay Recall, Story Memory Recognition, Verbal Learning Recognition, Design
Memory Recognition, and Picture Memory Recognition. Test items and domain construction
was based on previous editions of the WRAML and other tests purporting to measure specific
areas of cognitive functioning (Sheslow & Adams, 2003).
WRAML-2 reliability. Cronbach’s Alpha was used to determine the internal reliability
of the primary indices composing the General Memory Index (.90-.96): Verbal Memory Index
(.89-.94); Visual Memory Index (.82-.93); Attention/Concentration Index (.83-.91); and
Screening Memory Index (.90-.95). These values indicate adequate internal consistency and
high intercorrelations between related items of a specific index.
Test-retest reliability was evaluated by administration of the measure two times separated
by an average interval of 49 days and calculating a reliability coefficient: Verbal Memory Index
(.85); Visual Memory Index (.67); Attention/ Concentration Index (.68); General Memory Index
(.81); Memory Screening Index (.78). Coefficients indicate a relatively stable measure across
multiple administrations.
Inter-rater reliability is also relatively high for the WRAML-2. Inter-rater reliability was
calculated using Cohen’s Kappa. Kappa scores ranged from .977-.981, suggesting a high degree
of inter-rater reliability.
Given the degree of internal consistency of the subscales, the test-retest reliability, and
the inter-rater reliability, the measure has adequate reliability for the purposes of this experiment.
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WRAML-2 Validity: Internal validity was examined by evaluation of the intercorrelations of the primary indices and subtests of the WRAML-2. All correlations were found
to be significant at the p = .01 level. Thus, the items composing the subtests and indices of the
WRAML-2 are likely measuring a relatively uniform construct.
Internal validity was also examined using exploratory factor analyses in order to
determine the factor structure of the core subtests. A three-factor solution was found to fit the
data best from the six core subtests. A follow-up confirmatory factor analysis also supported the
three-factor model (AGFI=.973). According to the data from the analysis, over 70% of the
variance was explained by the three-factor model. In other words, construction of the test using
three primary indices composing the General Memory Index is supported by the factor analysis.
In addition to measures of internal validity, external validity of the WRAML-2 has also
been established. Specifically, convergence has been established between the WRAML-2 and
other related measures of memory and learning. For example, the WRAML-2 was correlated
with the Children’s Memory Scale (CMS), Test of Memory and Learning (TOMAL), and the
California Verbal Learning Test-II (CVLT-2). Correlations between the General Memory Index
and indices from other tests of memory and learning ranged from .44-.64, suggesting a moderate
relationship between the WRAML-2 and other measures of memory and learning. Lower, nonsignificant correlations were observed between indices of the WRAML-2 and unrelated indices
of memory and learning measures. The Visual Memory Index of the WRAML-2 was found to
be unrelated to tests of verbal memory on other measures (.03). In summary, the WRAML-2
exhibits both convergent and discriminant validity, which supports the construct and overall
external validity of this measure.
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Clinical validity has also been demonstrated with this measure. Specifically, the
WRAML-2 effectively distinguishes Alzheimer’s patients, traumatic brain injury, Parkinson’s,
and chronic alcohol abusers from normal healthy controls.
In summary, the WRAML-2 has adequate internal and external validity justifying the use
of this measure as an indicator of learning and memory abilities in this study.
RCMAS (Revised Children’s Manifest Anxiety Scale): The Revised Children’s
Manifest Anxiety Scale (RCMAS) is a widely used self-report measure designed to assess the
degree and nature of anxiety in children and adolescents aged 6 to 19 years old. This measure is
administrated through a series of 37 items to which the child answers “yes” or “no.” The “yes”
responses are considered descriptive of the child’s feelings or actions and are counted toward a
Total Anxiety score comprised of 4 subscales (Physiological Anxiety = 10 items,
Worry/Oversensitivity = 11 items, Social Concerns/Concentration = 7 items, and Lie = 9 items).
Because each “yes” answer adds to the Total Anxiety score, a high score is indicative of a high
level of anxiety in the child.
RCMAS Subscales and General Indexes: Three of the four subscales on the RCMAS
are factor-based. The first of these, Physiological Anxiety, is an index of the child’s
physiological response when experiencing anxiety. A high score on this subscale indicates that
the child has specific physiological responses that are normally experienced during moments of
anxiety. The second of these subscales is Worry/Oversensitivity. The items from this subscale
contain the word “worry” or insinuate in some way that the child is afraid, nervous, or generally
oversensitive to environmental pressures. A high score on this index suggests that the child may
internalize much of the anxiety experienced and become overwhelmed with trying to subside the
anxiety. There may be a strong need here for the child to learn coping mechanisms in order to
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verbalize feelings of anxiety more openly. The third factor-based subscale, Social
Concerns/Concentration, assesses the child’s concerns regarding face-to-face interactions with
another person and evaluates the degree of difficulty the child has in concentrating. A high score
on this subscale indicates anxiety that the child experiences because the child feels he or she
cannot meet the expectations laid out for them by the adults in their lives. The final subscale,
which is not factor-based, is the Lie subscale score, which is used to determine whether the child
has a negative intent to deliver false information to the examiner of the RCMAS. This index
includes items that say, “I like everyone I know,” and “I never lie.” Since these statements could
seldom be true of any person, much less a child, this could potentially suggest activity of
inaccurate self-reporting.
RCMAS Reliability: The Kuder-Richardson formula 20 (KR20) was used to determine
inter-item reliability given that items are scored dichotomously. The range for the average
reliability coefficients across the six study samples involving children from varying ethnicities,
sex, and ages is between .78 and .85. Thus, there is a high level of consistency across ethnicity,
sex, and age, with the exception of black females, in which case, the reliability coefficients are
remarkably lower at ages 6, 8, 10, and 11 than their white female cohorts. Overall, for most ages
and most ethnicity and sex groups, the alpha value for the Total Anxiety score equals or
surpasses .80, the alpha value most recommended by Wilson and Reynolds (1996) for use in
decision making. Internal consistency demonstrates coherence across the board for a number of
normal as well as special or unique study samples.
The RCMAS has not only a high level of internal consistency, but also has a consistently
low standard error of measurement (SEM) for the Total Anxiety Score. The coefficient alpha
values reported for a standardization sample of 5,000 children produced 1 SEM at a 68%
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confidence interval, 1.96 SEM at a 95% confidence interval, and a 2.58 SEM at a 99%
confidence interval. For the kindergarten children included in this sample, the SEM t-scores
were 4.58 for boys, 3.87 for girls, and 4.24 for the combined group of boys and girls. These
figures mirror the reliability estimates from earlier studies.
Test-retest reliability research has been done only for the Total Anxiety Score and the Lie
Subscale. In a sample of 534 elementary school-aged children who were tested approximately 9
months apart, a test-retest reliability coefficient of .68 was reported. Meanwhile, among the
same group of students, the Lie Subscale correlation was reported at .58 when tested 9 months
apart. The results from the Total Anxiety Score give justifiable evidence of constancy of general
trait anxiety over an elongated period of time. However, the results from the Lie subscale are
less favorable, but promising nonetheless. These results support the material stability of the
RCMAS and its function in assessing chronic anxiety in children.
In sum, the RCMAS has strong reliability attributes that should provide for facilitated
acquisition of consistent data in this study.
RCMAS Validity: Factor analysis currently reinforces the presence of a strong general
anxiety factor (Ag), represented by the Total Anxiety Score, and the factor-influenced subscales
as well as the Lie subscale. The RCMAS has strong construct validity when evidenced by the
comparison with other measures, including the State-Trait Anxiety Inventory for Children
(1973). Means and standard deviation was calculated for each scale: RCMAS, STAIC-Trait, and
STAIC-State; Pearson product-moment coefficients of correlation were used between each pair
of variables. The RCMAS correlated strongly with the STAIC-Trait scale (r=.85, p<.001);
however, the RCMAS did not correlate significantly with the STAIC-State scale (r=.35, p<.05).
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These results give ample support for the construct validity of the RCMAS as a measure
of chronic manifest anxiety, regardless of state or situational anxiety being experienced. Despite
the correlations between the self-reported measures and observed behaviors being smaller than
expected, overall the correlations produced were as anticipated. The RCMAS Total Anxiety
Score correlated with the STAIC-Trait scale at r = .65 for males and r = .67 for females.
Correlations between the RCMAS subscales and the five dimensions of behavior evaluated by
the Walker Problem Behavior Identification Checklist (1971) were nearly all positive
correlations, maintaining a total problem behavior score of r = .32 for males and r = .29 for
females. Correlations between child-reported anxiety symptoms and teacher-observed behavior
problems establish supportive evidence for the validity of the RCMAS.
In summary, the RCMAS has convergent and divergent validity, which gives credence to
the construct validity of the scale. Thus, this is a highly reliable measure with which to evaluate
the degree and nature of anxiety in children with VCFS, who frequently present with a number
of anxiety disorders.
Methods
Participants
Subjects included 22 children (11 males and 11 females) ages 6-16 years. Eleven of
these children (6 male and 5 female, mean age = 11.6) were individuals diagnosed with VCFS.
The other 11 children (6 male and 5 female, mean age = 12.5) served as controls. The
neurotypical children were all of average intellectual ability based on brief neuropsychological
testing using a two subtest intelligence scale. Previous experiments using cortisol analysis have
demonstrated large effect sizes (d = .66-.85), justifying the use of 20 subjects (Alpers, Abelson,
Wilhelm, & Roth, 2003; Kuhlmann & Wolf, 2006). Children with VCFS were recruited
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primarily through the VCFS network of support groups. Leaders of VCFS support groups were
contacted. The study was explained in detail to group heads and contact information and an
informational flyer was given to them. Following this, group leaders contacted their members
and asked if the families were interested in participating in the study. Interested families
contacted the experimenter directly, and formal informed consent procedures (described below)
commenced. Controls were recruited through peer nomination. Peer nomination and sibling
controls are two methods of recruitment commonly used to collect data on neurotypicals in
genetic research (Antshel, Conchelos, Lanzetta, Fremont, & Kates, 2005; Antshel et al., 2006;
Kates, Antshel et al., 2007). A list of a group of local children of matching ages was generated.
From this, a random sampling was taken.
Inclusion criterion for the current study included a VCFS diagnosis confirmed by FISH.
Controls were matched with VCFS individuals on the variables of age and sex. Exclusion
criteria for children with VCFS included the presence of pre- or perinatal pathology, head injury,
or substance abuse. In controls, the exclusion criteria consisted of the presence of learning
disabilities or other neurological insults. Informed consent was obtained from the parents of
children with VCFS and controls upon the first consultation following a demographic interview.
Specifically, potential candidates were contacted and the study was explained in detail. First, a
demographic interview was completed to ensure that participants met inclusion criteria. Next,
the procedure was explained. Participants were told that the experiment would involve a brief,
painless cortisol swab, which occurred at 11am on a weekend day followed by an afternoon of
cognitive testing. Participants were told that cognitive testing would take approximately 3-4
hours and involved an assessment of the child’s memory, social functioning, and adaptive
behavior. Parents were informed that neither they nor the child would receive results of testing
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or cortisol analysis and that the testing protocols would be de-identified, locked in a filing
cabinet, and housed in a secured laboratory. Additionally, parents were informed that
immediately following the cortisol analysis, swabs would be destroyed and no other information
would be obtained from them. After ensuring that the participants fully understood the
procedure, any potential risks, the scientific benefits, and the time investment of the current
study, they were scheduled for an appointment, and at that time written informed consent was
obtained from the parents of the children. As the children are minors, informed assent was also
obtained following a demonstration and thorough explanation of the procedures.
Design
The design of this experiment was a quasi-experimental study comparing two groups: A
VCFS group and a control group on cortisol levels, neurocognitive functioning, and social
competence. It was a between-groups design despite the fact that subjects were matched on
certain characteristics. Individuals were assigned to groups based on the presence or absence of
VCFS.
Procedures
Neuropsychological Procedure: Neuropsychological testing was completed by a trained
psychometrician at various testing locations. Assent and consent were obtained from the child
and his or her legal guardian, respectively, prior to the assessment. These assessments included
an evaluation of intellectual functioning, a comprehensive evaluation of verbal and visual
memory, attention, neurobehavioral functioning, emotional functioning, and adaptive
functioning. The children underwent the neuropsychological assessment in the late morning.
Cortisol swabs were taken before the assessment at 11 am to control for neurohormonal
responses to testing conditions. Testing order of experimental measures was as follows: (1)
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WRAML-2; (2) CBCL; (3) ABAS-II; (4) RCMAS-2. Total length of testing was approximately
2.5 hours, a time interval short enough to reduce the impact of fatigue on cognitive performance
(Lezak, 2008).
Cortisol Procedure: Subjects were interviewed prior to sample collection to determine
if the individual had had any recent injuries to the mouth or had not maintained adequate oral
hygiene over the last year, as both blood and other impurities can contaminate the sample and
confound results. Additionally, during the interview, subjects were asked if they had been to the
dentist within the last 48 hours or had brushed their teeth within the last 45 minutes as these
activities can increase the likelihood of oral irritation, which can release hormones that
contaminate the sample. Prior to collection, on the informed consent information packet,
subjects were instructed to avoid alcohol 24 hours prior to testing, eating a major meal 60
minutes prior to collection, dairy products 20 minutes before sample collection, and foods with
large amounts of sugar or caffeine 24 hours prior to collection. Finally, subjects were required to
rinse their mouth out with water 20 minutes before collection in order to remove any solid
particles from the oral cavity.
Cortisol samples were taken from children at approximately 11:00 a.m. Eleven in the
morning was selected due to the relative stability of cortisol flux at this time of day (Tout, de
Haan, Campbell, & Gunnar, 1998). Times earlier than 11 a.m. are more impacted by individual
differences in the child’s sleep-wake cycle and therefore can confound results (Dettling, Gunnar,
& Donzella, 1999). A similar problem has been reported in studies acquiring samples during the
late afternoon. In summary, acquiring time-locked samples reduces error associated with time of
day and provides a cost-effective way of collecting samples. Samples were acquired with a
standard buccal swab using the passive, unstimulated collection method. Children were directed
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to tilt their head forward allowing the saliva to pool near their bottom lip. A swab intended for
use with children 6 years or older was used to collect approximately 1ml of saliva. The material
that forms the oral swab is a non-toxic polymer material, which is inert and hypoallergenic. The
swab was placed in a collection vile made of polypropylene intended to preserve the molecular
structure of the steroid. The sample was then marked with both a numerical and bar code
identification tag, placed in an insulated container, and kept below 7-10 degrees Celsius.
Temperature was monitored throughout the process using a standard body thermometer.
Following the field collection process, the samples were shipped within 24-48 hours in
their insulated containers to the Salimetrics lab for salivary cortisol distribution analysis. Upon
arrival to the lab, the samples were thawed and centrifuged for approximately 15 minutes at 3000
rpms in order to separate cortisol from solute. Using the standard immunoassay saliva extraction
procedure, the steroid, cortisol, was then chemically isolated and concentrations per volume
calculated and reported (Gatti et al., 2009). The immunoassay procedure is useful because it
reduces the number of sample preparation steps including additional cycles of washing and
centrifuging, leading to reduced processing times and reduced cost (Rowe, Deo, Shofner, Ensor,
& Daunert, 2007). The immunoassay procedure works by isolating the free cortisol in the saliva
using cortisol antibodies to bind the steroid. Cortisol antibodies were developed via genetic
modification of aequorin. The saliva sample was then mixed with the aequorin to form an
aequorin-cortisol conjugate. Once the conjugate is formed, bioluminescence was used to
calculate the concentration of bound cortisol (Rowe et al., 2007). The immunoassay
methodology was selected due to its ability to detect very small differences in free cortisol
concentrations, 1 × 10−10 M (Rowe et al., 2007).
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Collection materials and vials were purchased from the Salimetrics Laboratory. Figure 1
shows the swab that was utilized and the collection tube and is a graphical representation of the
overall collection procedure. Cortisol samples were destroyed immediately following analysis to
comply with personal health information regulations. Data were de-identified and password
protected to comply with privacy regulations.

Figure 1. Salivary collection device and storage procedure. Following the swabbing procedure,
the collection tube cap is opened (1). The swab is placed inside the tube directly above the
centrifuge collection reservoir (2). The air-tight cap is then placed on the pre-labeled collection
tube in preparation for freezing (3).
Analysis
Analysis methods for both cortisol concentrations and neuropsychological test data
included standard descriptive techniques for continuous variables. Assumptions of normality
were checked using standard techniques including tests for normality, skew, and kurtosis
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(Tabachnick & Fidell, 1996). Effect sizes were also calculated and reported (H. Cohen et al.,
2006; J. Cohen, 1988, 1992, 1994).
Initial analysis included a between-groups ANOVA to determine if there are any baseline
cortisol differences (ug/dL), neurocognitive differences, or social/adaptive differences between
individuals with VCFS and controls. ANOVA was used to reduce alpha inflation.
In order to examine the behavioral ramifications of cortisol anomalies in individuals with
VCFS, Pearson r correlations assessing the relationship between cortisol levels and specific
subscales of the CBCL, ABAS-II, and the WRAML-2 were conducted. Table 1 describes the
specific analyses that were conducted in order to address the hypotheses in question and
correlation results.
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Table 1
Summary of Analyses and Correlation Results Between Cortisol Level and Subscales of the
CBCL, ABAS-II, WRAML-2, and RCMAS-2.
Subscale

Correlation Between Cortisol and Psychological Measures in VCFS Patients

CBCL

r-value

Anxious/Depressed

.144

Social Problems

.169

Thought Problems

-.406

Social Competency

-.109

ABAS-II_
Socialization

.563

Communication

-.222

WRAML-2
General Memory

-.342

Working Memory

.422

Attention/Concentration

-.516

RCMAS-2
Social Anxiety

.563

Total Anxiety

.487

_________________________________________________________________________________________
Note. CBCL = Child Behavior Checklist; ABAS-II= Adaptive Behaviors Assessment System 2 nd Edition; RCMAS2= Revised
Children’s Manifest Anxiety Scale 2nd Edition; WRAML-2= Wide Range Assessment of Memory and Learning 2 nd Edition.
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Results
This project examined the concentration of a specific stress hormone, cortisol, in
individuals with VCFS and its impact on cognitive and social functioning in individuals with
VCFS. To do this, saliva samples were obtained using the aforementioned analysis procedures
and the cortisol concentration calculated. Next, the performance on neuropsychological memory
and attention measures along with measures of social functioning in individuals with VCFS was
compared to control subjects. Finally, the relationship between the steroid hormone and scores
on specific cognitive and behavioral measures were examined in individuals with VCFS in order
to determine the impact of cortisol on these domains of functioning. Table 2 provides the mean
cortisol concentration for each group and corresponding effect sizes for individuals with VCFS
and Controls. Table 3 provides means and standard deviations for select subtests of the
WRAML-2 in individuals with VCFS and Controls. Table 4 summarizes mean scores of
behavioral measures of functioning including the CBCL, ABAS-II, and RCMAS-2 in individuals
with VCFS and Controls.
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Table 2
Mean Volume (cc) and SD of Cortisol in Individuals with VCFS and Controls
VCFS
Hormone

M

Cortisol

.25354

Controls
SD

M

SD__

Effect Size

.21342

.10408

.05443

1.01

d

Note. Cortisol concentrations are in micrograms per deciliter (ug/dL). Effect size is calculated as Cohen’s d.

Table 3
Mean Index Scores, Standard Deviations, and Effect Sizes for WRAML-2 indices in individuals
with VCFS and Controls
VCFS

Controls

WRAML-2 Index

M

SD

M

SD__

Effect Size

General Memory

74.03

12.76

109.45

14.22

-2.74

Working Memory

88.88

22.90

108.88

8.590

-1.70

Attn/Concentration

79.63

13.269

101.83

16.573

-1.55

d

Note. WRAML-2=Wide Range Assessment of Memory and Learning: 2 nd edition. Effect size is calculated as Cohen’s d.

58

Table 4
Means and Standard Deviations for Subscales of the CBCL, ABAS-II, and RCMAS in Children
With VCFS.
VCFS
Subscale

Controls

M

SD

M

SD

Effect Size d

Anxious/Depressed

56.26

8.01

50.09

Social Problems

57.13

8.57

50.54

Thought Problems

58.82

8.91

52.00

3.06

1.07

Social Competency

46.00

11.55

51.00

8.30

-.52

Socialization

100.69

19.73

112.81

10.52

-.80

Communication

7.36

3.21

11.81

1.66

-1.83

Social Anxiety

49.78

11.20

46.72

8.93

.33

Total Anxiety

50.43

11.47

46.81

9.61

.36

CBCL
2.50

.687

.95

1.14

ABAS-II_

RCMAS-2

_________________________________________________________________________________________
Note. CBCL = Child Behavior Checklist, M = 50, SD = 10 ; ABAS-II= Adaptive Behaviors Assessment System 2nd Edition, M =
100, SD = 15 for composite, M = 10, SD = 3 for individual scales; RCMAS2= Revised Children’s Manifest Anxiety Scale 2 nd
Edition, M = 50, SD = 10.

Specific Aim 1
It was predicted that salivary cortisol concentrations would be higher in individuals with
VCFS relative to controls. Figure 2 displays the mean cortisol concentration in individuals with
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VCFS and controls. Results indicated that mean cortisol concentration was significantly larger
in individuals with VCFS relative to controls, F(1, 20) = 5.436, p < .05 .

Figure 2. Mean cortisol concentrations (ug/dL) (+SE) for individuals with VCFS (n = 11) and
control individuals (n = 12).
Specific Aim 2
It was predicted that individuals with VCFS would perform significantly worse on tests
of memory learning as measured by the WRAML-2. In particular, general memory, attention
and concentration, and working memory indices would be lower in individuals with VCFS.
Results indicated significant difference in performance on these measures in individuals with
VCFS when compared with controls: General Memory, F(1, 20) = 37.875, p < .05;
Attention/Concentration, F(1, 20) = 11.513, p < .05; Working Memory, F(1, 16) = 5.127, p <
60

.05. Figure 3 displays the mean difference in standardized scores on these measures between
individuals with VCFS and controls.

Figure 3. Mean index scores on neurocognitive measures for individuals with VCFS (n = 11)
and control individuals (n = 11).
Specific Aim 3
It was hypothesized that children with VCFS would have lower ratings on measures of
social skills. As anticipated, individuals with VCFS exhibited significantly more symptoms
associated with lower social and adaptive functioning relative to controls: Anxious Depressed
(CBCL), F(1, 20) = 30.489, p < .05; Social Problems (CBCL), F(1, 20) = 5.375, p < .05;
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Thought Problems (CBCL), F(1, 20) = 52.535, p < .05; Social Competency (CBCL), F(1, 20) =
5.826, p < .05; Socialization (ABAS-II), F(1, 20) = 16.327, p < .05; Communication (ABAS-II),
F(1, 20) = 16.513, p < .05. Figure 4 displays the mean difference in T-scores on subscales of
the CBCL in individuals with VCFS and controls. Figure 5 displays the mean differences in
standardized scores on the ABAS-II in individuals with VCFS and controls.

Figure 4. Mean t-scores on CBCL subscales for individuals with VCFS (n = 11) and control
individuals (n = 11).
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Figure 5. Mean standardized scores on ABAS-II subscales for individuals with VCFS (n = 11)
and control individuals (n = 11).
Specific Aim 4
It was hypothesized that the cortisol level in individuals with VCFS would be
significantly correlated with cognitive measures and measures of social and adaptive functioning.
There were no significant correlations between cognitive measures and cortisol in individuals
with VCFS. That said, a significant negative correlation was observed between the General
Memory and Attention/Concentration indices of the WRAML-2 and cortisol concentrations in
controls: r(11) = -.778, p < .05; r(11) = -.618, p < .05. Figures 6 and 7 graphically depict the
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relationship between cortisol, the General Memory index score, and the Attention/Concentration
index score.
There were no significant correlations observed in individuals with VCFS on select
subscales of the ABAS-2, CBCL, and RCMAS-2. That said, the level of cortisol in control
individuals was negatively correlated to the social competency scale of the CBCL, r(11) = -.639,
p < .05. Figure 8 is a graphical representation of the correlation between cortisol concentration
and the social competency subscale of the CBCL in controls. Taken together these data suggest
that the individuals with VCFS have significantly larger concentrations of resting cortisol
relative controls and significantly worse cognitive performance.
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Figure 6. Relationship between average cortisol concentration (ug/dL) and the General Memory
Index Score of the WRAML-2 in Controls.
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Figure 7. Relationship between average cortisol concentration (ug/dL) and the Attention/
Concentration Index Score of the WRAML-2 in Controls.
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Figure 8. Relationship between average cortisol concentration (ug/dL) and the Total
Competency subscale of the CBCL.
Discussion
This study sought to identify the relationship between cortisol and severity of cognitive
and social impairments in individuals with VCFS. In particular, one goal of this research was to
elucidate brain-behavior relationships within the context of social cognition. As social cognition
has been implicated in numerous psychiatric disorders including pervasive developmental
disorders, psychosis, and mood disorders, understanding the neural substrates involved is
essential in determining the etiology of social deficits in these disorders, informing treatment,
and enhancing outcome. Recent studies have implicated elevated cortisol levels in both
cognitive and social impairments associated with the various psychological disorders comorbid
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with VCFS (Tout et al., 1998; Vythilingam et al., 2004; Walder et al., 2000). In this study,
salivary cortisol samples were taken from children with VCFS and neurotypicals in order to
evaluate difference in resting cortisol levels between the groups. These cortisol levels were then
correlated with measures of cognitive functioning, adaptive functioning, and social functioning
in order to help determine the role cortisol plays in the development of cognitive and social
deficits in this population.
Children with VCFS Show Elevated Cortisol Levels
The hypothesis that individuals with VCFS would have elevated resting cortisol levels
relative to controls was supported. Though this has been the first study to demonstrate this
elevation in a population of individuals with VCFS, it has been observed in related populations.
For example, such elevated levels of cortisol have been observed in children with ASD who
exhibit significant social and cognitive deficits (Richdale & Prior, 1992).
There are multiple theories regarding the etiology of cortisol elevation. The first theory
involves physiological mechanisms. It may be possible that children with VCFS have an
overactive hypothalamic-pituitary-adrenal axis that leads to the over-secretion of cortisol during
both stressful and non-stressful events. Select groups such as individuals who are predisposed to
the development of PTSD and children with neurodevelopmental disorders such as ASD exhibit
an elevated cortisol response when presented with minor to moderate stressors relative to control
counterparts (Carrion et al., 2002). Such a physiological profile may lead to increased startle
response in individuals with PTSD and emotional regulation issues in children with ASD. Thus,
hypersecretion of cortisol in response to minor stressors in daily living may account for the
elevated levels of the steroid observed in children with VCFS.
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Indeed, such hypersecretion of the HPA axis may be the result of traumatic events and
the over-exposure to stressful stimuli; however, another recent study suggests that the inability to
suppress cortisol is what mediates the deleterious neuroanatomical effects and psychopathology
and cognitive deficits associated long-term glucocorticoid exposure (Watson, Thompson,
Ritchie, Nicol Ferrier, & Young, 2006). Suppression of cortisol is one of the primary problems
associated with Cushing’s disease (Carlson, 2004), a disorder characterized by abnormally high
levels of glucocorticoids, cognitive impairments, and permanent changes in social functioning
(Heald et al., 2004). Cushing’s disease and cortisol suppression can be assessed using a
Dexamethasone Suppression Test. Dexamethasone is a steroid compound that is molecularly
similar to cortisol and binds to glucocorticoid receptors. After low-dose administration of
Dexamethosone, blood concentration of ACTH, an upstream precursor to glucocorticoids, is
reduced via biofeedback mechanisms responsible for HPA regulation. In individuals with
impairments in suppression of cortisol production, ACTH levels are not decreased, thereby
signifying impairment in cortisol regulation. This mechanism of impaired suppression of
cortisol may explain some of the difference between trauma-induced elevated cortisol levels and
developmental or genetic factors impacting basal cortisol levels. That is, overproduction of
cortisol, or hypersecretion, is often associated with stress exposure, while suppression
impairment may be more developmental in nature.
There is neuroanatomical evidence that may implicate deficits in ACTH suppression as a
mediating factor for elevated cortisol levels in children with VCFS. More specifically, the
hippocampus of the temporal lobe has been found to be significantly smaller in this population
(Jacobson, Rowe, & Lajiness-O'Neill, 2011; Kates et al., 2006). As the receptors get bound
with ligands, the negative feedback loop that leads to the suppression of ACTH production gets
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initiated via second messenger signals. As the hippocampus in children with VCFS is
significantly smaller, it stands to reason that they have may have fewer receptors at this site
meaning that regulation of ACTH production is going to be limited and temporally delayed.
Thus, it is this well-documented anomaly of the hippocampus in the temporal lobe of children
with VCFS that may contribute to deficits in suppression and the subsequent build-up of cortisol.
That said, it still remains unclear as to whether children with VCFS were born with smaller
hippocampi than controls or whether environmental factors such as exposure to significant
amounts of stress, which have been known to cause hippocampal atrophy (Starkman et al., 1999;
Suhr, Demireva, & Heffner, 2008), have contributed to the reduced hippocampal volumes. Due
to the technological limitations, complex sedation protocols, and resultant ethical considerations
involving imaging in infants, it is difficult to ascertain the directionality of the relationship
between the temporal atrophy, stress, and cortisol. Future advances in technology may allow for
early imaging in infants and may help determine the causal factors associated with HPA
dysregulation in children with VCFS.
As aforementioned, in this particular study, it is difficult to determine whether elevated
cortisol levels are developmentally mediated or caused by environmental stressors. That said,
there were no differences observed between individuals with VCFS and controls on a self-report
measure of total anxiety and social anxiety, suggesting that individuals with VCFS do not
necessarily interpret engagement in social interaction as a stressful or anxiety-provoking event,
nor are the children in this study endorsing significant levels of personal anxiety.
Though self-report measures did not indicate elevated anxiety or social anxiety, parent
report measures did indicate significantly higher levels of anxiety and depression relative to
controls. Thus, it may be possible that children with VCFS have difficulty labeling their own
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emotions. Perhaps the children with VCFS who are experiencing physiological stress in
response to certain situations though have become accustomed to the heightened arousal level
and autonomic symptoms associated with the response and therefore do not recognize the
situation as being particularly stressful. That is, the experience of stress may become
commonplace for these individuals, and the baseline for stimuli interpreted as being stressful is
raised, despite having the physiological responses associated with experiencing a stressor and the
corresponding cortisol elevation. Such a process has been observed in rats that were exposed to
a noxious audiologic stressor where, upon several exposures of the noxious stimuli, the rat
stopped responding behaviorally to the stressor while still having physiological responses to the
stimuli (Rabasa, Delgado-Morales, Munoz-Abellan, Nadal, & Armario, 2011). This is not unlike
a learned helplessness model in which escape or avoidance behaviors give way to more docile
acceptance (Seligman, 1972). In other words, the environment has not become any less stressful
to the children, but their baseline for behavioral reaction has shifted up, which is why they are
reporting less stress and anxiety than the corresponding observer report.
Another possible explanation for the cortisol elevation in children with VCFS involves an
epigenetic model of HPA dysregulation in developing fetuses and newborns. That is, there
might be an interaction between the maternal environment, the uterine environment, and the
genetic coding of proteins that impacts the development and functioning of the HPA axis. There
is some evidence from animal models to suggest that when a mother is exposed to significant
stressors, permanent changes occur in the composition and functioning of the fetal HPA axis
(Egliston, McMahon, & Austin, 2007; Wright, 2007). Specifically, regulation or suppression of
the stress response is impacted in offspring of mothers who have experienced significant
amounts of stress during pregnancy. Moreover, offspring exhibited higher resting cortisol levels
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and delayed returns to baseline cortisol following exposure to mild stressors. Indeed, maternal
stress may be one factor influencing the elevated cortisol levels in VCFS. More research is
necessary in order to understand the impact of prenatal stress on the aberrant functioning of the
HPA axis in individuals with VCFS.
In summary, it is unclear from these data whether children with VCFS are born with
anomalous physiological mechanisms, which fail to suppress ACTH production or whether
environmental stressors have a differential impact on the way these children secrete cortisol.
Specific measures and records of stressful events and Dexamethosone Suppression Tests may be
necessary in order to reach more definitive conclusions regarding the etiology of the elevated
cortisol levels.
Children with VCFS Perform Significantly Poorer on Selected Tests of Memory and
Learning
The hypothesis that children with VCFS would exhibit reduced cognitive abilities relative
to control counterparts was supported. Specifically, children with VCFS exhibit poorer
performance in general memory ability, attention and concentration ability, and working memory
ability. This finding is not surprising given the high rate of ADHD and LD observed in this
population. According to Antshel et al. (2007), children with VCFS exhibit an inattentive
subtype of ADHD characterized by poor ability to focus and short attention span. One of the
causal mechanisms for ADHD in this population is poor self-monitoring ability mediated by
functional deficits in the frontal lobes and volumetric anomalies in the caudate nucleus
(Castellanos et al., 1994) of children with VCFS. Specifically, children with VCFS show
increased activation in the frontal lobe during a computerized continuous performance task.
Such increased activation suggests that in order to perform well on the test, the individual needs
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to work harder and recruit resources from other regions of the brain. Such recruitment is
commonly observed in studies of functional neuroimaging in individuals with ADHD.
In addition to the frontal lobes, the caudate nucleus of the basal ganglia has been
implicated in the regulation of attention and the ability to maintain vigilance (Garrett et al.,
2008). Individuals with ADHD performing cancellation and continuous performance tasks show
decreased activation in these areas during the test period (Schneider et al., 2010). Additionally,
in control populations an asymmetry in this structure is observed (Hynd et al., 1993).
Specifically, neurotypicals have a larger right caudate nucleus relative to the left. However, in
children with ADHD, the asymmetry is absent and there is no significant difference between the
right and the left caudate. Children with VCFS who exhibit symptoms associated with ADHD
have a right and left caudate that are volumetrically indistinguishable (Sugama et al., 2000).
Therefore, it is possible that volumetric anomalies in this structure are mediating some of the
symptoms of inattention in this population.
Genetics may also play a role in the inattention observed in this population. Individuals
with VCFS and comorbid ADHD have a low-activity COMT allele. In fact, individuals with
VCFS have only a single copy of the COMT gene and therefore have the lowest COMT activity
(Gothelf, Michaelovsky et al., 2007; Lachman et al., 1996). The COMT gene is responsible for
coding for an enzyme associated with the breakdown of the neurotransmitter dopamine. As a
result of the low activity variant in individuals with VCFS, too much dopamine accumulates in
regions associated with the maintenance of attention such as the frontal lobes and select
structures of the basal ganglia. Excessive dopamine in these regions have been associated with
symptoms of inattention (Turic et al., 2005), rapid mood changes (Papolos et al., 1998), and
psychosis (Murphy, Jones, & Owen, 1999). Given these findings, it is highly possible that the
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poor performance on measures of inattention may be related to the COMT gene and subsequent
dopamine modulation.
The inattention and inability to concentrate may be one of the factors impacting the poor
social skills observed in children with VCFS. That is, the children do not attend to social cues
such as facial expressions, eye gaze, and other social norms. As a result, the children do not
learn to engage reciprocally in social interactions and have decreased overall social competence.
Additionally, given the involvement of dopamine in social reciprocity and social responsiveness
(Nagaraj, Singhi, & Malhi, 2006), it is likely that the low activity COMT variant expressed in
children with VCFS may also be contributing to their social skills deficits. In other words, not
only do the children have deficits attending to, learning, and using social cues, but they also may
find social interaction less rewarding in general as a result of aberrant dopamine modulation.
More research is necessary to determine the links between COMT, dopamine, cortisol, attention,
and social functioning, in order to determine the magnitude and specific contributions of each of
these variables.
In addition to inattention and concentration deficits, individuals with VCFS in this study
exhibited general memory deficits. These data are consistent with previous findings examining
the cognitive profile of children with VCFS (Debbane, Glaser, & Eliez, 2008; Kates, Krauss et
al., 2007; Lajiness-O'Neill et al., 2006; Majerus, Van der Linden, Braissand, & Eliez, 2007;
Swillen et al., 1999). Children with VCFS exhibit nonverbal learning deficits, recognition
deficits for both verbal and nonverbal information, and difficulties suppressing irrelevant
content, which all contribute to the general memory impairment commonly observed in this
population. It has been reported that the general memory deficits observed in this population
relate to neuroanatomical and functional inefficiencies in bilateral hippocampus of children with
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VCFS. As previously stated, children with VCFS have decreased volume in their hippocampus
(Jacobson et al., 2011; Kates et al., 2006). These volumetric anomalies have been correlated
with decreased performance on tests of memory and learning relative to neurotypical children.
In particular children with VCFS exhibit a NLD profile (Lajiness-O'Neill et al., 2006) though
recently deficits have been observed in serial learning of verbal information and recognition of
verbal information (Majerus et al., 2007). In summary, children with VCFS exhibit deficits in
general ability characterized by nonverbal memory and learning deficits and circumscribed
verbal learning deficits. It is likely that these deficits are caused by neuroanatomical and
functional deficits in substructures of the temporal lobe.
Working memory abilities were also found to be reduced in children with VCFS relative
to controls. These data have also been reported and therefore the data reported in this study is
consistent with previous findings (Coman et al., 2010; De Smedt et al., 2008; Kates, Krauss et
al., 2007; Lajiness-O'Neill, 2005; van Amelsvoort et al., 2004). Working memory requires a
combination of neurological structures working in concert. Specifically, working memory is
supported by sub-regions of the frontal lobe and the parietal lobe. For example, an examination
of frontal lobe structures in individuals with decreased working memory ability found decreased
activity in the frontal lobes. With regard to the parietal lobe, individuals with VCFS have
exhibited volumetric and functional anomalies in this lobe of the brain (Eliez et al., 2000).
Additionally, Diffusion Tensor Imaging (DTI) studies have examined the white matter pathways
connecting the frontal and parietal lobes in this population and children with VCFS and found
that the Fractional Anisotropy (FA) values in white matter tracts in the supramarginal gyrus and
angular gyrus were positively correlated with performance on the arithmetic subscale of the
WAIS/WISC, suggesting that aberrant connectivity between the frontal and parietal lobes may
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contribute to spatial working memory deficits observed in this population (Barnea-Goraly, Eliez,
Menon, Bammer, & Reiss, 2005). Moreover, studies have found decreased activation in the
temporal lobe of patients with working memory deficits (White, Hongwanishkul, & Schmidt,
2011). Children with VCFS exhibit deficits and functional anomalies in all of these areas
supporting working memory.
As aforementioned, decreased frontal volumes and aberrant activation of oribitofrontal
and ventromedial prefrontal cortex has been observed in this population (Kates et al., 2010;
Kates et al., 2006). The functional deficits associated with both the frontal lobe and temporal
lobe have again been attributed to increased dopamine levels in this region, which impact both
receptor sensitivity, overall efficiency of dopamine transmission, and production of factors
essential to the maintenance of healthy cellular functioning and memory encoding (Gothelf,
Schaer, & Eliez, 2008). It is possible that due to increased exposure to dopamine as a result of
the inability to degrade dopamine, down regulation of D2 receptors occurs. D2 receptors have
been shown to be essential for working memory (Goldman-Rakic, 1999; Wang, Vijayraghavan,
& Goldman-Rakic, 2004). Moreover, the presence of excessive amounts of dopamine has been
shown to lead to the down regulation of D2 receptors (Ginovart, Farde, Halldin, & Swahn, 1999;
Zemlan, Hitzemann, Hirschowitz, & Garver, 1985). For example, in individuals with
schizophrenia, release mediated down-regulation of central and cortical D2 receptors has been
observed along with reduced receptor density (Ginovart et al., 1999; Zemlan et al., 1985). As
working memory deficits have been observed in the schizophrenic population as well, it stands to
reason that D2 receptor modulation may contribute to deficits observed in children with VCFS.
Additionally, evidence from cocaine abuse studies suggest that particular working
memory deficits are mediated by the underproduction of Nuclear factor kappa B (NFkappaB),
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which is a modulator of oxidative stress and a key component of short-term memory formation
(Muriach et al., 2010). Following administration of high doses of exogenous cocaine, a synthetic
dopamine agonist, NFkappaB was greatly reduced in frontal regions. Corresponding deficits in
memory performance were also observed. Thus, it seems that an interaction between
neuroanatomical deficits in the frontal cortex, parietal lobe, and temporal lobe along with
overproduction of dopamine may mediate the significant difference in working memory
performance in individuals with VCFS and controls. More research is necessary in order to
understand the unique role that dopamine and NFkappaB plays in the development of working
memory deficits in individuals with VCFS.
To summarize, it is unclear what the role of cortisol is in mediating cognitive deficits
observed in this population. More research is necessary in order to determine whether elevated
cortisol levels underlie some of the morphometric anomalies in children with VCFS. As will be
shown, there may not be a direct relationship between elevated cortisol and other symptoms such
as working memory attention, general memory. However, cortisol might share an indirect role
or secondary role to dopamine in the impairment and symptomatology observed in this
population.
The Relationship Between Cortisol and Cognitive and Behavioral Measures of Functioning
The hypothesis that cortisol levels would be correlated with select measures of cognitive
functioning and social competence in individuals with VCFS was not supported. Specifically, no
relationship between cortisol and general memory, attention and concentration, or working
memory was observed. Moreover, a significant relationship was not observed between cortisol
level and anxiety/depression, social problems, thought content problems, and social competency
in individuals with VCFS. Additionally, cortisol levels were unrelated to measures of adaptive
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functioning including social skills and communication. Finally, in children with VCFS cortisol
was not related to measures of social anxiety or total anxiety. Though it is tempting to conclude
that cortisol may be unrelated to these cognitive and behavioral measures, drawing such a
conclusion is premature given the relationships observed in the control group. In the control
group, a significant negative correlation was observed between cortisol and social competence as
measured by the CBCL. Additionally, a negative correlation was observed between cortisol and
the attention/concentration subscale of the WRAML-2. Thus, in controls, aspects of
neurocognitive functioning are strongly correlated with resting cortisol levels. This may imply
that in children with VCFS, another physiological or neuroanatomical mechanism may be
influencing the strength and direction of the relationship between cortisol and neurocognitive and
behavioral measures.
One possible explanation for the differences observed in the cortisol relationships
between controls and individuals with VCFS is receptor sensitivity or down regulation. Down
regulation of receptors is observed when there is a high presence of a certain endogenous or
exogenous chemical messenger in the brain (Carlson, 2004). Essentially, receptor modulation is
a physiological mechanism through which neurons attempt to maintain homeostasis. Put simply,
receptors on the surface of cells are rendered inactive in response to high levels of transmitter.
As a result, more transmitter is required in order to produce the same behavioral effect. Such
receptor modulation governs the process of physiological and behavioral tolerance to certain
drugs (Carlson, 2004). Glucocorticoid receptor down regulation has been observed in animal
models. In response to long-term water exposure and restraint, the number of glucocorticoid
receptors observed in the brains of rats were greatly reduced, leading to hyposuppression of the
stress response (Huizenga et al., 2000; Mizoguchi et al., 2001). Given the long-term exposure to
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elevated glucorticoids in individuals with VCFS, it may be possible that receptor down
regulation may be occurring throughout the limbic system and prefrontal cortex. Such receptor
down regulation may be the reason that the cortisol does not have a significant relationship with
measures of cognitive and social functioning. It also explains the different findings between the
two groups. Since individuals without VCFS are not exposed to the high levels of
glucocorticoids for long periods of time, receptor down regulation in key areas of the brain
associated with memory, learning, and social functioning may not have occurred, and
performance on cognitive and behavioral measures is still affected. Thus, it may be that children
with VCFS have developed somewhat of a tolerance to cortisol through receptor modulation and
therefore do not exhibit the strong correlations between cortisol, cognition, and social
functioning seen in controls. Further research examining the temporal relationship between
receptor down regulation and cognitive and behavioral functioning in individuals with VCFS is
necessary in order to determine if exposure to high levels of glucocorticoids throughout
development impacts the effect that cortisol has on symptomatology.
Though glucocorticoid receptor modulation explains the differential cortisol findings in
VCFS and controls, it does not explain the relativity poor cognitive performance and higher
levels of symptomatology observed in the VCFS children in this study. Thus, an additional
mechanism may also be acting along with cortisol and may significantly contribute to deficits
observed in this population. One possible mechanism mediating the cognitive and social deficits
associated with VCFS is dopamine. Due to the low-activity COMT variant expressed in children
with VCFS, dopamine levels in this population are high (Gothelf et al., 2008; Papolos et al.,
1998; van Amelsvoort et al., 2008; Yu, Zhang, Huang, Ding, & Li, 2007). Such high levels of
dopamine have been associated with impaired memory performance (B. L. Murphy, Arnsten,
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Goldman-Rakic, & Roth, 1996), attention/concentration deficits (Russell et al., 2006), and social
deficits (Liddle, 2000). Thus, it is possible that both dopamine and cortisol act in concert to
produce the deficits observed in VCFS. Moreover, given the COMT variant in children with
VCFS ,it is likely that these children have significantly higher levels of dopamine than their
control counterparts. These elevated dopamine levels may contribute to D1 and D2 receptor
insensitivity in some regions of the brain associated with reward and attention while
simultaneously contributing to symptoms associated with psychosis. The combination of
dopamine and cortisol may have impacted the ability to observe a significant relationship
between cortisol alone and the neuropsychological functioning of the children with VCFS. That
is, the elevated dopamine levels may have exacerbated deficits and impacted test scores in such a
way as to make the relationship with cortisol non-linear.
Treatment Implications
Given what is observed in neurotypical children regarding the relationship between
cortisol level, cognitive performance, and social competence, this study has some relevant
treatment implications. Reduction of cortisol level has been shown to improve mood impairment
and cognitive functioning (Baker et al., 2010). When used to treat bipolar disorder, mifepristone,
an antiglucocorticoid drug, was effective in reducing hypercortisolaemia. Following the
reduction of glucocorticoids, verbal fluency, spatial recognition abilities, and working memory
abilities improved significantly relative to a no-treatment control group (Young et al., 2004). In
addition, mood symptoms were also reduced. To date there have not been any published studies
examining the impact of mifepristone on cognitive functioning and social competency in
individuals with VCFS. Given the high rate of bipolar disorder in this population and the
relative effectiveness of the drug to treat both mood and cognitive symptoms, it may be a useful
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treatment in this population, and further research is necessary in order to determine the efficacy
of the drug in the alleviation of symptoms in this population.
In addition to drug therapy, behavioral interventions have also been shown to reduce
cortisol levels and improve cognitive functioning (Baker et al., 2010). Following a regimen of
daily moderate exercise, individuals with Alzheimer’s disease showed an increase in their ability
to regulate the HPA axis and a corresponding decrease in cortisol level. Performance on
neurocogntive measures in the area of executive functioning and short-term memory were
significantly improved relative to controls. These data further suggest that regulation of cortisol
is effective in reducing cognitive symptoms.
In summary, regulation of cortisol may be an important treatment target for both
individuals with VCFS and other populations exhibiting high levels of cortisol. Both behavioral
and physiological treatments have been shown to reduce cortisol levels. More research is
necessary in order to determine the optimal levels of cortisol and the specific impact that a
reduction in cortisol levels would have on cognition and social functioning in patients with
VCFS and other neurodevelopmental disorders.
Limitations
One of the primary limitations of this study was sample size. Indeed, the sample size was
sufficient to be able to detect differences in resting cortisol levels. However, given the
individual variability of neurocognitive performance, a larger sample size would have enhanced
the power and decreased the likelihood of making a type-II error.
Sample composition is another limitation of this study. Due to the fact that subjects were
recruited through the VCFS support group, there may be confounds associated with individuals
who have access to the group. Additionally, these individuals are often apprised of recent
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treatments, and it is possible that the children in the support group may have received more
surgical, pharmacological, and psychological treatment than VCFS children not in the support
group.
Another limitation is that only one physiological variable was examined in this study. It
is likely that multiple factors contribute to the high levels of cortisol levels and cognitive and
behavioral symptomatology observed in this population. It would be informative to incorporate
multiple variables to determine the relative contribution of several possible etiological variables.
Finally, another limitation and confound in this study was the inability to control for
various medications. Due to the wide range of medications taken in the VCFS sample and the
inability to have patients not take their medication for any extended period of time, it was
difficult to statistically control for any one type of medication (i.e. psychostimulants, antibiotics,
antidepressants, anxiolytics, etc.). Future studies of cognitive and social functioning in this
population should examine and control for the specific effects of the medication the individuals
are taking. This would require a significantly larger sample size and a more consistent
medication record between patients.
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